data_5wdz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5wdz _Structure_validation_residue.Date_analyzed 2017-11-24 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HA ' ' OE2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.58 -41.13 98.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.586 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.4 m -93.58 87.95 5.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.27 -43.94 98.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.255 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -121.42 149.09 43.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.27 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -127.28 158.63 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.77 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -89.82 117.96 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.2 p -94.94 -19.71 20.01 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.02 129.73 82.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 110.579 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.26 129.05 33.14 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.46 2.107 . . . . 0.0 112.916 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -160.06 125.17 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.506 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -122.51 89.31 49.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.284 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.91 134.55 13.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.223 1.949 . . . . 0.0 112.577 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.72 3.14 23.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.725 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -94.06 8.5 41.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -82.16 119.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.264 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -108.17 -34.95 6.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.031 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -140.0 159.55 41.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.244 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 144.29 29.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 110.296 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -119.74 145.01 46.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.07 126.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.535 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.19 124.82 66.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 110.709 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.32 129.53 39.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.92 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 3.6 p -72.98 -53.17 11.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.152 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.15 -165.65 42.35 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.19 -34.98 87.82 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.039 2.493 . . . . 0.0 113.259 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -64.78 -40.53 95.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 30' ' ' SER . 94.8 m -118.1 124.68 48.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.278 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.07 96.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.37 142.34 36.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.3 m -67.81 138.28 56.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.865 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 7' ' ' CYS . 46.5 mt-10 -104.48 125.47 50.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.42 128.66 75.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.2 tt -132.38 141.58 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.077 0.465 . . . . 0.0 110.867 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.17 151.54 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.777 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -113.56 122.59 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.665 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -91.4 153.54 19.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -21.93 62.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.304 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.49 10.47 12.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 25.88 64.3 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -101.62 145.72 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -117.83 135.08 54.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.745 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.0 tp -128.41 128.19 43.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.83 129.82 37.72 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.945 0.403 . . . . 0.0 110.397 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.3 mt -116.37 145.84 42.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.953 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -92.22 118.75 68.28 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.164 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.67 -20.63 69.66 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.119 2.546 . . . . 0.0 113.936 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -68.91 -20.99 64.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.592 0.234 . . . . 0.0 111.608 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.28 132.55 35.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 111.083 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.91 -42.76 99.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.182 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -62.36 -29.96 70.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.8 -42.71 96.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 109.895 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -61.72 -38.68 88.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.725 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -61.47 -40.14 93.46 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.288 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.488 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.8 t -61.27 -48.65 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.335 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.67 -48.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.694 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.92 -46.94 79.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.72 -41.69 91.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.488 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 33.0 m-85 -71.31 -36.3 71.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.663 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.051 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.48 -41.06 96.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.573 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.2 m -97.56 127.21 43.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.61 -27.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 111.133 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -133.79 143.21 48.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -132.13 158.8 40.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.896 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -108.86 143.51 37.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.388 . . . . 0.0 110.946 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.4 p -90.6 -11.01 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.652 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -78.95 124.46 84.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.91 133.66 59.38 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.874 2.382 . . . . 0.0 113.191 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -154.6 111.62 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -136.33 89.03 19.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.792 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.65 142.36 94.1 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.759 2.306 . . . . 0.0 112.379 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -81.67 2.55 29.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.037 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.61 14.7 27.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.74 119.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -89.53 -48.73 7.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.78 150.48 49.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.155 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.18 116.6 26.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.184 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -106.68 144.62 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.406 0.622 . . . . 0.0 112.011 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.9 t -115.58 128.79 72.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.613 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.9 mt -106.29 127.0 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.874 0.368 . . . . 0.0 111.08 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.12 142.26 57.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 78.5 p -70.74 -41.49 71.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.0 -174.34 43.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.533 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.79 -31.32 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.042 1.828 . . . . 0.0 112.986 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.72 -38.56 70.49 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 30' ' ' SER . 79.0 m -105.58 119.44 39.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.76 94.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.068 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -106.62 146.36 30.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.625 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -74.01 162.91 28.54 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.589 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -125.55 137.73 53.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.9 mt -117.67 128.69 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 tt -129.98 138.0 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.207 0.527 . . . . 0.0 111.028 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -114.74 148.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.117 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.83 121.96 46.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.57 152.45 22.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.223 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -59.78 -24.93 64.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.878 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -80.43 7.58 9.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.139 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.01 63.24 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.648 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 mmm-85 -101.76 147.45 26.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -120.96 145.43 47.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.676 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -105.07 128.67 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.116 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.22 142.1 47.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 58' ' ' VAL . 41.1 t0 -92.9 116.3 66.28 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.61 -18.89 62.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.071 2.514 . . . . 0.0 113.835 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -68.1 -21.66 64.94 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 0.0 111.565 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.66 132.43 34.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.15 -40.24 95.32 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.086 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.483 ' O ' HG21 ' A' ' 61' ' ' VAL . 68.5 p-90 -63.19 -30.69 71.79 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 52' ' ' ASP . 53.4 t -63.46 -43.69 98.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.413 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.97 -42.11 97.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -62.76 -41.13 99.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.314 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 57' ' ' TRP . 64.4 t -63.17 -46.63 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.36 -47.51 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.211 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -40.97 91.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.613 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -62.3 -49.08 77.05 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.869 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 48.8 m-85 -71.57 -37.12 71.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.476 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.244 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -64.62 -40.1 94.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.685 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.6 m -92.97 87.32 5.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.25 -44.96 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 110.227 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.66 147.75 50.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.943 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -128.15 158.84 36.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.8 158.35 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.3 p -91.06 -3.43 57.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -127.51 73.25 77.98 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.681 0.277 . . . . 0.0 111.6 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 161.79 34.3 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.973 2.449 . . . . 0.0 113.319 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.23 130.04 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.488 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -112.88 98.05 43.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.4 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.08 155.25 33.47 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 112.615 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -80.07 3.66 19.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.502 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -96.62 17.54 16.17 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.58 121.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.04 -47.49 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.913 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.07 147.42 52.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tt -119.53 112.51 19.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.893 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -110.19 147.55 33.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.0 111.375 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -126.96 150.67 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.607 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.3 mt -119.86 124.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.612 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.75 138.99 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 p -72.16 -55.12 7.8 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.814 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.16 -154.22 20.13 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.113 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.5 -25.69 3.63 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.233 1.955 . . . . 0.0 112.772 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -71.08 -40.19 71.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.6 m -113.46 131.7 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.34 92.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -131.14 149.29 52.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 111.782 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.2 m -64.05 138.57 58.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.984 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -116.94 139.76 50.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 0.0 111.677 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -118.34 129.97 73.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.66 135.9 58.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.932 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.98 149.12 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.86 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.89 123.2 49.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.94 154.79 20.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.3 p -60.04 -19.64 53.88 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.567 0.542 . . . . 0.0 112.131 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.52 5.27 36.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.008 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.49 23.15 57.16 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -99.75 148.08 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -118.83 131.8 56.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.9 mt -120.67 143.89 48.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.669 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 t -98.75 128.45 44.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.094 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -115.61 143.31 45.54 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.408 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -95.87 113.97 63.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.78 -15.87 45.0 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 113.638 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.74 -37.66 85.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.398 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -74.17 126.22 30.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.692 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -62.78 -41.37 99.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.52 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -63.19 -30.47 71.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.366 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.1 -44.5 99.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.067 0.46 . . . . 0.0 109.768 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -62.11 -39.24 91.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -60.9 -42.28 97.73 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.83 -44.57 88.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.88 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.93 -48.17 89.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.392 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.16 -41.13 95.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -63.65 -43.66 96.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.937 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.33 -47.02 87.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.062 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.105 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.231 0.121 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.75 -39.97 94.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.113 0.482 . . . . 0.0 111.534 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.9 m -93.21 92.47 7.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.69 -45.02 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.219 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -128.18 148.52 50.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.928 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -128.46 158.92 37.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.033 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.467 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 47.1 t80 -108.15 142.4 38.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.992 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 80.7 p -62.18 -36.34 81.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.05 71.64 81.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 O-C-N 122.175 -0.328 . . . . 0.0 111.776 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.94 156.23 52.54 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.446 2.097 . . . . 0.0 112.55 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -87.79 119.92 28.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.489 ' ND1' HG13 ' A' ' 61' ' ' VAL . 22.2 t-160 -116.24 100.72 53.7 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.15 139.64 79.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.005 2.47 . . . . 0.0 112.448 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.13 0.56 40.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.452 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.58 17.83 20.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.425 HD13 ' NE2' ' A' ' 18' ' ' HIS . 39.6 pt -66.83 147.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.57 -29.81 12.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.458 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -139.39 148.49 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.224 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -128.99 106.85 9.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.642 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -100.24 128.05 46.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.236 0.541 . . . . 0.0 111.477 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.68 125.72 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.53 124.59 71.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.116 0.484 . . . . 0.0 111.635 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.14 154.86 30.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 77.6 p -70.43 -42.91 70.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.794 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.98 -162.12 31.94 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.38 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -16.18 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.727 2.285 . . . . 0.0 114.222 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -104.79 -2.07 25.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 30' ' ' SER . 41.3 t -127.73 132.75 49.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.81 93.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.85 156.47 45.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.5 p -74.33 161.9 29.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.547 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -149.69 149.55 30.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.702 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.76 129.05 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.2 tt -128.49 137.25 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.42 152.68 17.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.622 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -118.74 123.53 45.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.41 157.95 19.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.142 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.6 p -59.95 -21.19 60.87 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.655 0.597 . . . . 0.0 112.453 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.0 6.7 34.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.92 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.61 58.96 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.082 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -99.0 128.33 45.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -104.74 130.64 52.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 111.043 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -119.4 144.48 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.097 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.75 127.9 47.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.3 mt -112.51 145.52 40.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.76 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.23 114.59 59.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.09 -17.96 40.37 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.966 2.444 . . . . 0.0 113.438 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -70.19 -21.43 63.04 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 14' ' ' SER . 81.1 mm-40 -85.7 126.37 33.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.88 -40.52 97.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.652 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -63.33 -34.11 76.99 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.295 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.86 -44.41 96.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.144 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -62.23 -39.87 94.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.069 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -61.2 -41.63 97.17 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.489 HG13 ' ND1' ' A' ' 18' ' ' HIS . 76.5 t -67.45 -44.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.23 -47.43 93.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.16 -39.78 94.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.64 -44.98 95.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.853 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.27 -39.21 86.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.176 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -67.81 -23.19 65.16 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.9 m -97.89 85.01 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.739 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.56 -45.39 85.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.498 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -130.24 145.05 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.216 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.6 p -130.58 158.99 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -92.47 140.61 29.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.3 m -61.01 -39.6 90.35 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.04 76.12 76.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.565 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.83 158.93 51.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.73 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.18 140.23 33.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.423 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -111.6 99.98 46.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.09 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.04 145.92 96.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.079 2.519 . . . . 0.0 112.644 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -80.01 3.17 20.99 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.202 0.525 . . . . 0.0 110.821 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.18 20.88 12.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.195 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 65' ' ' PHE . 83.9 mt -75.72 120.41 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.778 0.323 . . . . 0.0 110.152 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -89.02 -47.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -133.86 149.18 51.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tt -120.55 115.21 22.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -104.97 142.8 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.203 0.525 . . . . 0.0 111.523 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.75 128.44 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.93 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.6 mt -108.42 123.88 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.41 146.49 46.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.8 p -70.79 -42.81 69.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.08 -162.73 26.93 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.735 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.35 -24.91 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.038 1.825 . . . . 0.0 112.385 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -39.41 70.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 30' ' ' SER . 83.3 m -113.9 131.15 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.73 0.3 . . . . 0.0 111.618 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.0 95.91 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.816 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -118.56 159.04 24.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.316 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.6 p -79.45 164.5 23.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.08 139.62 51.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 111.245 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.68 127.56 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 tt -129.66 138.22 54.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.289 0.566 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.05 147.33 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -109.45 117.51 34.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -86.34 153.7 21.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.281 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m -57.04 -34.24 68.03 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.821 0.7 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.57 6.78 3.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.615 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.69 22.98 60.87 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.666 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.11 142.19 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.061 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -116.34 131.65 56.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.881 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.7 mt -121.36 146.05 47.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.1 t -102.92 126.3 50.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -109.57 145.35 36.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.731 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -90.11 114.46 60.98 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.06 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.81 -16.76 41.92 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.048 2.499 . . . . 0.0 113.318 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -62.12 -37.23 84.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.24 121.76 23.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.772 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -63.93 -31.66 72.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.315 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.09 -43.85 99.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.41 -38.85 91.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.97 -42.09 97.65 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.43 -44.37 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.94 -47.25 94.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 98.7 mt-10 -64.58 -41.45 96.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.836 0.351 . . . . 0.0 110.539 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.01 -43.93 94.16 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 22' ' ' ILE . 77.7 t80 -61.33 -46.89 88.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 29.3 mt . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.48 -39.57 94.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.413 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.92 98.9 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.16 -43.46 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.319 0.58 . . . . 0.0 109.888 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -124.29 152.77 42.65 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 70.1 p -126.36 158.5 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 11.6 t80 -81.3 118.39 22.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.781 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -98.66 -15.18 19.51 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.506 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 60.3 mtpt -72.38 131.01 85.25 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.496 0.188 . . . . 0.0 110.951 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.77 71.7 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.255 2.636 . . . . 0.0 113.863 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -118.8 127.11 53.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.625 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -111.26 99.15 42.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.82 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.72 129.37 10.78 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.176 1.917 . . . . 0.0 112.752 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -81.09 3.25 23.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.565 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.8 15.42 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -77.87 95.64 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -71.67 -42.77 67.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.51 149.6 49.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.149 0.499 . . . . 0.0 111.53 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.29 120.92 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.03 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -109.9 139.58 44.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 111.365 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -116.83 126.68 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.787 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 28' ' ' ILE . 47.0 mm -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.08 122.42 21.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.624 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 9.4 p -72.51 -43.47 63.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.581 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.37 48.36 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.139 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.27 -25.63 26.03 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.318 2.012 . . . . 0.0 112.83 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.07 -40.3 87.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 30' ' ' SER . 92.0 m -117.3 119.77 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.714 0.292 . . . . 0.0 110.609 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.69 95.3 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -98.31 131.03 44.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.3 m -63.66 139.01 58.73 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.118 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.05 127.9 51.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.094 0.473 . . . . 0.0 112.227 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.35 129.09 75.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.9 tt -131.34 138.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.253 0.549 . . . . 0.0 110.995 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -112.81 149.76 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -116.31 120.02 37.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.27 153.62 23.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.665 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.5 p -59.7 -21.1 60.15 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.49 0.494 . . . . 0.0 112.122 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.52 7.27 17.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 110.91 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.2 20.62 66.82 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -101.78 127.55 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.647 0.26 . . . . 0.0 110.899 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -104.45 129.61 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.363 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.66 140.68 49.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.22 131.86 44.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.0 mt -117.0 145.93 43.36 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.196 0.522 . . . . 0.0 111.691 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 58' ' ' VAL . 45.1 t0 -97.1 117.12 66.05 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.35 -18.58 53.76 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 123.222 2.615 . . . . 0.0 113.913 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.26 -24.23 66.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -81.87 135.12 35.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.062 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.04 -42.07 98.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -62.87 -29.65 70.92 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 52' ' ' ASP . 57.8 t -64.45 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.505 ' O ' HG12 ' A' ' 62' ' ' VAL . 42.5 tt0 -60.71 -38.5 85.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.59 -39.37 90.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.199 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.439 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.6 t -61.0 -47.83 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.351 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 59' ' ' GLN . 15.0 p -72.4 -41.96 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.02 -42.87 79.97 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.28 -41.6 73.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.439 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 32.0 m-85 -71.37 -37.19 71.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.023 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.168 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.8 m -90.28 95.91 10.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.912 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -83.79 -27.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.569 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -130.07 143.66 50.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.431 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 p -131.41 159.57 37.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 111.746 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.85 128.75 55.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -64.25 -37.27 86.88 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -128.36 72.77 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.65 159.56 48.46 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.493 2.129 . . . . 0.0 111.85 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.427 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 20.5 p90 -76.27 168.26 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -109.62 98.34 32.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.403 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 17' ' ' PHE . 3.2 Cg_exo -81.91 124.11 4.34 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.959 2.439 . . . . 0.0 112.479 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.14 -1.05 51.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.45 20.78 13.17 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.94 120.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.148 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -101.85 -35.8 8.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.532 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -132.14 144.35 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.728 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.02 110.79 13.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -101.5 137.47 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.0 111.456 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -117.46 129.08 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.064 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.85 124.02 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.16 147.71 48.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 p -71.66 -53.01 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.5 -159.98 29.22 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.738 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.06 -24.13 4.11 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.043 1.829 . . . . 0.0 112.288 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -73.06 -39.96 65.46 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.85 131.84 55.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.754 0.311 . . . . 0.0 111.053 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.66 93.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.139 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -129.35 158.1 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.849 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.4 p -71.5 158.11 36.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.654 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -129.69 139.61 51.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.929 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -120.8 129.63 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.118 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.9 tt -128.73 135.64 61.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.05 0.452 . . . . 0.0 110.443 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.78 148.08 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.0 110.765 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.37 124.14 49.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.855 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.01 159.3 17.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.731 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.3 p -59.56 -21.21 59.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.415 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.34 5.2 35.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.075 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 25.85 54.53 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.026 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -101.07 142.45 32.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -116.04 131.38 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -120.44 145.19 47.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.55 126.34 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 84.7 mt -116.91 145.23 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -108.59 113.74 59.64 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.72 -12.93 33.88 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.652 2.901 . . . . 0.0 115.514 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.04 -21.43 66.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.142 0.428 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -95.86 135.61 37.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.718 0.294 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -62.3 -39.03 91.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.503 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.44 -45.03 92.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.159 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 51' ' ' LEU . 63.4 t -62.52 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -61.41 -38.22 86.33 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.556 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -59.96 -41.05 91.08 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.438 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.427 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 75.5 t -64.09 -46.51 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.72 -47.26 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.656 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.24 -38.94 92.86 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.417 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 47.6 m-85 -70.81 -36.53 73.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.71 0.29 . . . . 0.0 111.749 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.312 -0.852 . . . . 0.0 111.133 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 99.7 m . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.692 0.282 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -61.86 -39.89 93.47 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.308 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.3 m -88.77 127.16 35.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.8 pt -104.01 -9.55 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -147.93 137.57 22.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.142 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.8 p -129.64 160.24 33.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 9.2 t80 -101.93 117.57 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -93.44 -12.44 29.77 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 35.4 mmtp -84.61 122.78 74.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.77 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 57' ' ' TRP . 74.4 Cg_exo -54.67 129.39 34.75 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.455 2.104 . . . . 0.0 112.794 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -160.93 137.17 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -119.4 90.64 42.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.78 124.38 11.83 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.556 2.171 . . . . 0.0 112.178 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -83.72 0.54 46.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.788 0.328 . . . . 0.0 111.452 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.83 14.22 29.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -75.22 119.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.938 0.399 . . . . 0.0 110.073 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -102.51 -42.96 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -130.41 149.69 51.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 111.478 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -118.52 122.03 41.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.375 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.48 143.73 38.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.807 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.7 128.97 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.376 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -104.43 123.24 58.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.45 139.36 47.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.9 p -71.19 -42.14 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.83 -170.51 36.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.591 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.43 -22.64 15.94 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.065 1.844 . . . . 0.0 112.316 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -71.14 -39.8 71.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' SER . 71.3 m -116.67 131.23 57.0 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.39 95.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.217 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -111.33 158.27 19.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.003 0.43 . . . . 0.0 111.783 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.8 p -83.11 166.38 18.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.465 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.5 mt-10 -125.24 143.44 50.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 110.986 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -117.49 127.92 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.997 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 49' ' ' LEU . 16.5 tt -127.32 137.66 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.168 0.508 . . . . 0.0 110.537 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.73 148.4 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.973 0.416 . . . . 0.0 110.745 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.66 123.14 48.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.75 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.99 153.92 20.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.5 p -60.07 -19.5 53.39 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.597 0.561 . . . . 0.0 112.17 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 3.98 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.93 56.72 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.233 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -101.46 139.19 37.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.872 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.44 129.29 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.672 0.272 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 40' ' ' ILE . 87.7 mt -120.51 135.9 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.629 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.86 123.95 46.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -117.29 148.04 42.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -87.72 118.4 69.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.134 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.56 -19.34 64.36 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.171 2.581 . . . . 0.0 113.853 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.18 -21.24 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.83 133.59 35.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.007 0.432 . . . . 0.0 111.02 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.35 -40.51 96.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . 0.502 ' CD2' ' HA ' ' A' ' 16' ' ' PRO . 56.7 p-90 -64.0 -30.35 71.43 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.644 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.17 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.043 0.449 . . . . 0.0 109.927 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.96 -40.0 91.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.317 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -63.05 -38.34 90.8 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.553 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 66.4 t -59.81 -47.57 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.377 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.06 -38.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.54 -44.63 77.87 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.65 -41.6 96.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 41.0 m-85 -70.9 -34.88 72.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 111.577 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.679 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.513 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 8.5 m . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.72 0.295 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -63.37 -41.14 98.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.082 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.7 m -93.28 93.13 8.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.72 -44.34 98.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -116.43 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -130.12 158.46 39.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.413 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t80 -108.48 138.74 44.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 71.0 m -61.71 -41.45 97.62 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -131.8 72.84 79.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.2 Cg_endo -72.07 156.23 56.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.752 2.302 . . . . 0.0 113.358 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.47 131.01 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.843 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -100.83 107.43 49.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.656 0.265 . . . . 0.0 110.79 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.58 153.51 34.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.932 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.28 3.25 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.402 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -98.12 20.2 12.79 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.83 118.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -91.75 -45.74 8.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.72 149.07 52.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.779 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.88 114.7 19.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.457 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -107.33 136.39 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.206 0.527 . . . . 0.0 111.482 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -117.35 127.74 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.954 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -108.49 121.39 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 110.719 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.22 144.28 50.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.83 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -72.17 -54.48 9.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.68 -165.09 25.1 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.113 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.93 -29.14 8.68 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.676 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -71.48 -38.38 71.24 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 t -113.53 128.46 56.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.742 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.58 93.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -127.31 139.97 52.52 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -64.72 137.64 57.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.595 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.513 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.2 mt-10 -125.56 140.9 52.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 130.73 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.58 141.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -114.57 149.46 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -110.6 122.34 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.178 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.27 153.17 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.7 p -60.57 -19.88 58.82 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.69 0.619 . . . . 0.0 112.124 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -85.13 4.22 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.94 58.93 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.324 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -101.26 158.81 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.545 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -128.1 133.33 49.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.4 mt -123.9 142.54 51.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.215 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.8 m -100.12 133.14 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.71 148.34 39.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -98.64 110.41 56.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.49 -14.3 36.73 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.086 2.524 . . . . 0.0 113.54 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -61.68 -37.08 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.648 ' HG3' ' O ' ' A' ' 14' ' ' SER . 77.5 mm-40 -77.29 127.88 33.37 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.84 -40.34 97.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -64.52 -32.8 74.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.87 -43.23 97.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -61.22 -41.41 96.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.51 -46.0 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.601 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.65 -49.2 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.77 -43.06 89.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.0 -40.04 83.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.978 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -62.37 -48.59 79.08 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.943 -179.521 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.5 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.5 0.19 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -62.27 -40.86 97.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.066 0.46 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.2 m -105.99 105.46 15.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.24 -47.2 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.845 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.21 149.01 52.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 111.303 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 p -129.8 156.92 43.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.128 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.42 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 35.9 t80 -108.7 142.46 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.6 p -62.04 -35.64 79.21 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.58 73.53 80.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.505 0.193 . . . . 0.0 110.964 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.31 156.74 54.57 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.652 2.235 . . . . 0.0 113.159 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -86.88 143.54 27.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.105 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.06 90.95 42.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.268 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.22 147.74 94.47 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.195 2.597 . . . . 0.0 112.582 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -81.06 3.27 23.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -96.52 16.37 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.892 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.1 mt -76.06 118.38 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.74 -44.34 8.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -130.62 149.18 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.42 115.91 21.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -108.31 132.23 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.32 0.581 . . . . 0.0 112.046 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.8 t -122.49 128.47 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.381 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.1 148.63 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.105 0.479 . . . . 0.0 111.776 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.95 148.95 36.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.084 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 79.5 p -70.59 -40.56 73.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.713 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.88 -156.62 36.27 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.922 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.87 -20.09 7.91 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.167 1.911 . . . . 0.0 112.217 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -70.76 -40.18 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.498 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 30' ' ' SER . 97.6 m -124.48 149.08 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.67 -4.58 55.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.05 139.9 41.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 111.6 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.6 m -64.62 137.41 57.82 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.083 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.99 132.89 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 111.753 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -117.53 130.28 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.9 tt -132.15 144.18 37.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 110.896 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.16 149.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.759 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -114.37 119.54 37.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.423 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.63 153.18 20.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.0 p -60.53 -20.13 59.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.063 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.52 4.09 37.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.839 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.11 22.46 57.25 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.22 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -100.89 144.15 30.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.318 . . . . 0.0 111.118 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.29 130.28 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.995 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.4 141.7 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 87.5 m -97.06 134.64 40.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.392 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.28 144.15 44.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.778 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -96.55 116.51 66.16 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.06 -13.25 39.17 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.291 2.66 . . . . 0.0 113.946 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.52 -38.43 87.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -79.63 127.66 32.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.751 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -69.19 -35.62 76.45 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -65.21 -31.81 73.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.635 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.6 -42.11 94.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -61.78 -38.24 87.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.59 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -60.48 -41.31 93.97 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.888 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.1 -44.33 95.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.292 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -61.47 -47.13 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.843 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.45 -39.58 94.1 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.357 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.24 -46.03 92.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.284 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -68.1 -38.15 81.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.436 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.171 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.61 153.12 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.95 17.51 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -26.7 68.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.475 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.79 139.48 55.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.5 140.69 22.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.566 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.522 ' HA ' ' OE2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -88.06 80.2 7.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.58 -41.13 98.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.586 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.4 m -93.58 87.95 5.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.27 -43.94 98.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.255 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -121.42 149.09 43.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.27 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -127.28 158.63 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.77 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -89.82 117.96 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.2 p -94.94 -19.71 20.01 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.02 129.73 82.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 110.579 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.26 129.05 33.14 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.46 2.107 . . . . 0.0 112.916 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -160.06 125.17 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.506 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -122.51 89.31 49.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.284 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.91 134.55 13.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.223 1.949 . . . . 0.0 112.577 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.72 3.14 23.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.725 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -94.06 8.5 41.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -82.16 119.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.264 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -108.17 -34.95 6.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.031 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -140.0 159.55 41.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.244 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 144.29 29.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 110.296 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -119.74 145.01 46.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.07 126.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.535 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.19 124.82 66.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 110.709 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.32 129.53 39.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.92 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 3.6 p -72.98 -53.17 11.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.152 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.15 -165.65 42.35 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.19 -34.98 87.82 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.039 2.493 . . . . 0.0 113.259 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -64.78 -40.53 95.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.689 ' O ' ' HB2' ' A' ' 30' ' ' SER . 94.8 m -118.1 124.68 48.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.278 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.07 96.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.37 142.34 36.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.3 m -67.81 138.28 56.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.865 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.522 ' OE2' ' HA ' ' A' ' 7' ' ' CYS . 46.5 mt-10 -104.48 125.47 50.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.42 128.66 75.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.2 tt -132.38 141.58 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.077 0.465 . . . . 0.0 110.867 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.17 151.54 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.777 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -113.56 122.59 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.665 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -91.4 153.54 19.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -21.93 62.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.304 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.49 10.47 12.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 25.88 64.3 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -101.62 145.72 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -117.83 135.08 54.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.745 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.0 tp -128.41 128.19 43.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.83 129.82 37.72 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.945 0.403 . . . . 0.0 110.397 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.3 mt -116.37 145.84 42.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.953 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -92.22 118.75 68.28 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.164 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.67 -20.63 69.66 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.119 2.546 . . . . 0.0 113.936 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -68.91 -20.99 64.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.592 0.234 . . . . 0.0 111.608 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.28 132.55 35.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 111.083 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.91 -42.76 99.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.182 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -62.36 -29.96 70.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.8 -42.71 96.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 109.895 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -61.72 -38.68 88.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.725 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -61.47 -40.14 93.46 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.288 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.488 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.8 t -61.27 -48.65 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.335 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.67 -48.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.694 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.92 -46.94 79.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.72 -41.69 91.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.488 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 33.0 m-85 -71.31 -36.3 71.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.663 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.051 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.963 0.411 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.94 153.85 39.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.691 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.39 11.63 27.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.24 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.92 -37.09 85.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.555 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.9 120.46 13.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.116 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -131.86 159.07 39.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.176 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.6 m -74.11 123.75 25.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.48 -41.06 96.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.573 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.2 m -97.56 127.21 43.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.61 -27.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 111.133 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -133.79 143.21 48.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -132.13 158.8 40.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.896 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -108.86 143.51 37.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.388 . . . . 0.0 110.946 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.4 p -90.6 -11.01 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.652 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -78.95 124.46 84.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.91 133.66 59.38 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.874 2.382 . . . . 0.0 113.191 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -154.6 111.62 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -136.33 89.03 19.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.792 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.65 142.36 94.1 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.759 2.306 . . . . 0.0 112.379 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -81.67 2.55 29.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.037 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.61 14.7 27.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.74 119.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -89.53 -48.73 7.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.78 150.48 49.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.155 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.3 tt -119.18 116.6 26.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.184 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -106.68 144.62 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.406 0.622 . . . . 0.0 112.011 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.9 t -115.58 128.79 72.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.613 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.9 mt -106.29 127.0 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.874 0.368 . . . . 0.0 111.08 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.12 142.26 57.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.614 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 78.5 p -70.74 -41.49 71.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.0 -174.34 43.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.533 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.79 -31.32 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.042 1.828 . . . . 0.0 112.986 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.72 -38.56 70.49 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.614 ' O ' ' HB2' ' A' ' 30' ' ' SER . 79.0 m -105.58 119.44 39.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.76 94.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.068 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -106.62 146.36 30.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.625 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -74.01 162.91 28.54 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.589 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -125.55 137.73 53.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.9 mt -117.67 128.69 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 tt -129.98 138.0 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.207 0.527 . . . . 0.0 111.028 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.9 m -114.74 148.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.117 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.83 121.96 46.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.0 mt -87.57 152.45 22.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.223 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -59.78 -24.93 64.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.878 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -80.43 7.58 9.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.139 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.01 63.24 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.648 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 57.5 mmm-85 -101.76 147.45 26.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.864 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.9 mt -120.96 145.43 47.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.676 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -105.07 128.67 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.116 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.22 142.1 47.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 58' ' ' VAL . 41.1 t0 -92.9 116.3 66.28 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -61.61 -18.89 62.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.071 2.514 . . . . 0.0 113.835 -178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -68.1 -21.66 64.94 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 0.0 111.565 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -84.66 132.43 34.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.15 -40.24 95.32 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.086 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.483 ' O ' HG21 ' A' ' 61' ' ' VAL . 68.5 p-90 -63.19 -30.69 71.79 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 52' ' ' ASP . 53.4 t -63.46 -43.69 98.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.413 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.97 -42.11 97.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -62.76 -41.13 99.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.314 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 57' ' ' TRP . 64.4 t -63.17 -46.63 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.36 -47.51 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.211 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -40.97 91.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.613 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -62.3 -49.08 77.05 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.869 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 48.8 m-85 -71.57 -37.12 71.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.476 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.244 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.113 0.483 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.34 70.54 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.069 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.444 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 57.6 mtpt -96.42 4.84 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -93.3 9.83 34.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.83 138.77 48.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.95 135.48 47.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.28 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -97.84 81.11 2.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -64.62 -40.1 94.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.685 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.6 m -92.97 87.32 5.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.25 -44.96 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 110.227 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -127.66 147.75 50.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.943 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -128.15 158.84 36.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.8 158.35 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.3 p -91.06 -3.43 57.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -127.51 73.25 77.98 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.681 0.277 . . . . 0.0 111.6 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 161.79 34.3 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.973 2.449 . . . . 0.0 113.319 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.23 130.04 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.488 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.8 m-70 -112.88 98.05 43.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.4 -179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.08 155.25 33.47 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 112.615 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -80.07 3.66 19.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.502 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -96.62 17.54 16.17 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.58 121.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.04 -47.49 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.913 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.07 147.42 52.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.2 tt -119.53 112.51 19.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.893 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -110.19 147.55 33.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.0 111.375 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -126.96 150.67 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.607 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.3 mt -119.86 124.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.612 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.75 138.99 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.2 p -72.16 -55.12 7.8 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.814 -178.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.16 -154.22 20.13 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.113 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.5 -25.69 3.63 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.233 1.955 . . . . 0.0 112.772 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.444 ' NE2' ' HA ' ' A' ' 3' ' ' LYS . 84.6 m-70 -71.08 -40.19 71.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.6 m -113.46 131.7 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.34 92.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -131.14 149.29 52.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 111.782 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 59.2 m -64.05 138.57 58.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.984 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -116.94 139.76 50.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 0.0 111.677 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -118.34 129.97 73.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.7 tt -131.66 135.9 58.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.932 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.0 m -112.98 149.12 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.86 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.89 123.2 49.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.94 154.79 20.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.3 p -60.04 -19.64 53.88 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.567 0.542 . . . . 0.0 112.131 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.52 5.27 36.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.008 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.49 23.15 57.16 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -99.75 148.08 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -118.83 131.8 56.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.9 mt -120.67 143.89 48.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.669 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 t -98.75 128.45 44.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.094 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -115.61 143.31 45.54 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.408 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -95.87 113.97 63.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -67.78 -15.87 45.0 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 113.638 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.74 -37.66 85.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.398 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -74.17 126.22 30.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.692 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -62.78 -41.37 99.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.52 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -63.19 -30.47 71.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.366 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.1 -44.5 99.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.067 0.46 . . . . 0.0 109.768 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -62.11 -39.24 91.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -60.9 -42.28 97.73 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 74.6 t -66.83 -44.57 88.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.88 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.93 -48.17 89.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.392 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.16 -41.13 95.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -63.65 -43.66 96.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.937 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.33 -47.02 87.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.062 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.105 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.948 0.404 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.29 91.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.62 -11.3 60.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.689 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.72 1.74 57.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.158 0.504 . . . . 0.0 110.257 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.466 HD21 ' O ' ' A' ' 30' ' ' SER . 68.4 tp -87.67 122.7 31.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.827 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -149.67 163.1 38.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -92.57 96.31 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.75 -39.97 94.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.113 0.482 . . . . 0.0 111.534 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.9 m -93.21 92.47 7.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.3 mt -63.69 -45.02 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.219 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.6 mtmt -128.18 148.52 50.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.928 179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -128.46 158.92 37.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.033 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 47.1 t80 -108.15 142.4 38.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.992 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.432 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 80.7 p -62.18 -36.34 81.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.05 71.64 81.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 O-C-N 122.175 -0.328 . . . . 0.0 111.776 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.94 156.23 52.54 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.446 2.097 . . . . 0.0 112.55 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -87.79 119.92 28.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.489 ' ND1' HG13 ' A' ' 61' ' ' VAL . 22.2 t-160 -116.24 100.72 53.7 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.15 139.64 79.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.005 2.47 . . . . 0.0 112.448 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.13 0.56 40.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.452 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.58 17.83 20.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.425 HD13 ' NE2' ' A' ' 18' ' ' HIS . 39.6 pt -66.83 147.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.57 -29.81 12.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.458 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -139.39 148.49 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.224 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -128.99 106.85 9.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.642 179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.4 tpt180 -100.24 128.05 46.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.236 0.541 . . . . 0.0 111.477 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.68 125.72 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.53 124.59 71.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.116 0.484 . . . . 0.0 111.635 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.14 154.86 30.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.489 ' O ' ' HB3' ' A' ' 34' ' ' CYS . 77.6 p -70.43 -42.91 70.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.794 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.98 -162.12 31.94 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.38 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -16.18 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.727 2.285 . . . . 0.0 114.222 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -104.79 -2.07 25.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.489 ' HB3' ' O ' ' A' ' 30' ' ' SER . 41.3 t -127.73 132.75 49.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.81 93.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.85 156.47 45.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.5 p -74.33 161.9 29.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.547 179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -149.69 149.55 30.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.702 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.76 129.05 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.2 tt -128.49 137.25 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 0.0 110.645 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 26.8 m -115.42 152.68 17.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.622 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -118.74 123.53 45.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -87.41 157.95 19.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.142 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.6 p -59.95 -21.19 60.87 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.655 0.597 . . . . 0.0 112.453 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.0 6.7 34.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.92 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.61 58.96 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.082 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -99.0 128.33 45.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 99.9 mt-10 -104.74 130.64 52.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 111.043 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -119.4 144.48 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.097 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.75 127.9 47.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.3 mt -112.51 145.52 40.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.76 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.23 114.59 59.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.09 -17.96 40.37 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.966 2.444 . . . . 0.0 113.438 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -70.19 -21.43 63.04 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.432 ' HG3' ' O ' ' A' ' 14' ' ' SER . 81.1 mm-40 -85.7 126.37 33.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.88 -40.52 97.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.652 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -63.33 -34.11 76.99 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.295 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.86 -44.41 96.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.144 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -62.23 -39.87 94.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.069 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -61.2 -41.63 97.17 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.489 HG13 ' ND1' ' A' ' 18' ' ' HIS . 76.5 t -67.45 -44.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 178.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.23 -47.43 93.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.16 -39.78 94.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.64 -44.98 95.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.853 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.27 -39.21 86.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.176 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.653 0.263 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.32 43.78 13.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.4 1.62 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.19 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 60.04 39.44 19.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.206 0.527 . . . . 0.0 110.893 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.432 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 68.8 tp -109.66 123.68 49.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.264 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -128.98 147.25 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.578 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.5 m -87.74 89.9 8.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -67.81 -23.19 65.16 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.9 m -97.89 85.01 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.739 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.56 -45.39 85.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.498 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -130.24 145.05 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.216 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.6 p -130.58 158.99 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -92.47 140.61 29.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.3 m -61.01 -39.6 90.35 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.04 76.12 76.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.565 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.83 158.93 51.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.73 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.18 140.23 33.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.423 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -111.6 99.98 46.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.09 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.04 145.92 96.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.079 2.519 . . . . 0.0 112.644 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -80.01 3.17 20.99 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.202 0.525 . . . . 0.0 110.821 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.18 20.88 12.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.195 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.424 ' HB ' ' CZ ' ' A' ' 65' ' ' PHE . 83.9 mt -75.72 120.41 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.778 0.323 . . . . 0.0 110.152 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -89.02 -47.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -133.86 149.18 51.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tt -120.55 115.21 22.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 179.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -104.97 142.8 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.203 0.525 . . . . 0.0 111.523 -179.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.75 128.44 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.93 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.6 mt -108.42 123.88 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.41 146.49 46.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.533 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.8 p -70.79 -42.81 69.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.08 -162.73 26.93 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.735 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.35 -24.91 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.038 1.825 . . . . 0.0 112.385 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.432 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 95.1 m-70 -71.75 -39.41 70.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 30' ' ' SER . 83.3 m -113.9 131.15 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.73 0.3 . . . . 0.0 111.618 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.0 95.91 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.816 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -118.56 159.04 24.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.316 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.6 p -79.45 164.5 23.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.08 139.62 51.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 111.245 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.68 127.56 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.6 tt -129.66 138.22 54.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.289 0.566 . . . . 0.0 111.119 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 29.3 m -115.05 147.33 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.491 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -109.45 117.51 34.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.8 mt -86.34 153.7 21.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.281 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m -57.04 -34.24 68.03 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.821 0.7 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.57 6.78 3.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.615 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.69 22.98 60.87 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.666 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 -101.11 142.19 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.061 -178.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -116.34 131.65 56.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.881 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.7 mt -121.36 146.05 47.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.1 t -102.92 126.3 50.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -109.57 145.35 36.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.731 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -90.11 114.46 60.98 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.06 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.81 -16.76 41.92 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.048 2.499 . . . . 0.0 113.318 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -62.12 -37.23 84.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.24 121.76 23.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.772 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -63.93 -31.66 72.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.315 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.09 -43.85 99.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.41 -38.85 91.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.97 -42.09 97.65 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.43 -44.37 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.94 -47.25 94.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.517 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 98.7 mt-10 -64.58 -41.45 96.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.836 0.351 . . . . 0.0 110.539 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.01 -43.93 94.16 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.424 ' CZ ' ' HB ' ' A' ' 22' ' ' ILE . 77.7 t80 -61.33 -46.89 88.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 29.3 mt . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.955 0.407 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.62 153.44 39.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.8 17.27 21.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.74 -37.76 87.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.82 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.52 121.77 22.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.109 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.62 148.58 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.613 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.31 97.92 10.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.48 -39.57 94.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.413 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.92 98.9 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.16 -43.46 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.319 0.58 . . . . 0.0 109.888 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -124.29 152.77 42.65 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.435 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 70.1 p -126.36 158.5 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.506 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 11.6 t80 -81.3 118.39 22.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.781 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -98.66 -15.18 19.51 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.506 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 60.3 mtpt -72.38 131.01 85.25 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.496 0.188 . . . . 0.0 110.951 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.77 71.7 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.255 2.636 . . . . 0.0 113.863 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -118.8 127.11 53.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.625 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -111.26 99.15 42.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.82 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.72 129.37 10.78 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.176 1.917 . . . . 0.0 112.752 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -81.09 3.25 23.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.565 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.8 15.42 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -77.87 95.64 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -71.67 -42.77 67.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.51 149.6 49.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.149 0.499 . . . . 0.0 111.53 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 58.5 tp -119.29 120.92 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.03 179.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 85.0 mtp180 -109.9 139.58 44.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 111.365 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -116.83 126.68 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.787 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.452 HD11 HG22 ' A' ' 28' ' ' ILE . 47.0 mm -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.159 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.08 122.42 21.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.624 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 9.4 p -72.51 -43.47 63.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.581 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.37 48.36 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.139 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.27 -25.63 26.03 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.318 2.012 . . . . 0.0 112.83 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.07 -40.3 87.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.624 ' O ' ' HB2' ' A' ' 30' ' ' SER . 92.0 m -117.3 119.77 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.714 0.292 . . . . 0.0 110.609 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.69 95.3 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -98.31 131.03 44.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.3 m -63.66 139.01 58.73 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.118 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.05 127.9 51.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.094 0.473 . . . . 0.0 112.227 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.35 129.09 75.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.9 tt -131.34 138.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.253 0.549 . . . . 0.0 110.995 -179.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 31.2 m -112.81 149.76 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -116.31 120.02 37.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.27 153.62 23.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.665 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.5 p -59.7 -21.1 60.15 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.49 0.494 . . . . 0.0 112.122 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.52 7.27 17.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 110.91 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.2 20.62 66.82 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -101.78 127.55 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.647 0.26 . . . . 0.0 110.899 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -104.45 129.61 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.363 . . . . 0.0 110.994 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.66 140.68 49.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.22 131.86 44.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 82.0 mt -117.0 145.93 43.36 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.196 0.522 . . . . 0.0 111.691 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 58' ' ' VAL . 45.1 t0 -97.1 117.12 66.05 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.35 -18.58 53.76 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 123.222 2.615 . . . . 0.0 113.913 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.26 -24.23 66.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.1 mm-40 -81.87 135.12 35.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.062 -179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.04 -42.07 98.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 61.4 p-90 -62.87 -29.65 70.92 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 52' ' ' ASP . 57.8 t -64.45 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.505 ' O ' HG12 ' A' ' 62' ' ' VAL . 42.5 tt0 -60.71 -38.5 85.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 178.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.59 -39.37 90.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.199 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.439 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.6 t -61.0 -47.83 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.351 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.505 HG12 ' O ' ' A' ' 59' ' ' GLN . 15.0 p -72.4 -41.96 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.02 -42.87 79.97 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.28 -41.6 73.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.439 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 32.0 m-85 -71.37 -37.19 71.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.023 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.77 92.69 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.861 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.26 4.96 52.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.336 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 59.56 39.06 21.98 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.214 0.53 . . . . 0.0 110.937 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.471 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 69.1 tp -109.92 124.93 52.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.527 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -125.45 134.5 52.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.476 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 m -78.57 92.52 4.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.168 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.8 m -90.28 95.91 10.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.912 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -83.79 -27.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.569 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -130.07 143.66 50.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.431 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.1 p -131.41 159.57 37.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 111.746 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.85 128.75 55.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -64.25 -37.27 86.88 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -128.36 72.77 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.65 159.56 48.46 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.493 2.129 . . . . 0.0 111.85 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.427 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 20.5 p90 -76.27 168.26 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -109.62 98.34 32.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.403 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 17' ' ' PHE . 3.2 Cg_exo -81.91 124.11 4.34 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.959 2.439 . . . . 0.0 112.479 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.14 -1.05 51.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.45 20.78 13.17 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.94 120.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.148 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -101.85 -35.8 8.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.532 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -132.14 144.35 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.728 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.9 tt -127.02 110.79 13.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.24 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.6 mtt85 -101.5 137.47 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.0 111.456 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -117.46 129.08 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.064 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.85 124.02 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.16 147.71 48.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 p -71.66 -53.01 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.5 -159.98 29.22 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.738 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.06 -24.13 4.11 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.043 1.829 . . . . 0.0 112.288 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.471 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 99.8 m-70 -73.06 -39.96 65.46 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.85 131.84 55.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.754 0.311 . . . . 0.0 111.053 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.66 93.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.139 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -129.35 158.1 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.849 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.4 p -71.5 158.11 36.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.654 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -129.69 139.61 51.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.929 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 87.3 mt -120.8 129.63 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.118 179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 16.9 tt -128.73 135.64 61.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.05 0.452 . . . . 0.0 110.443 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.1 m -112.78 148.08 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.0 110.765 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.37 124.14 49.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.855 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.01 159.3 17.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.731 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.3 p -59.56 -21.21 59.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.415 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.34 5.2 35.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.075 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 25.85 54.53 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.026 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -101.07 142.45 32.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -116.04 131.38 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 110.823 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -120.44 145.19 47.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.55 126.34 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.427 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 84.7 mt -116.91 145.23 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -108.59 113.74 59.64 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.72 -12.93 33.88 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.652 2.901 . . . . 0.0 115.514 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.04 -21.43 66.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.142 0.428 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -95.86 135.61 37.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.718 0.294 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -62.3 -39.03 91.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.503 179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.44 -45.03 92.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.159 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.427 ' CG1' ' HB3' ' A' ' 51' ' ' LEU . 63.4 t -62.52 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -61.41 -38.22 86.33 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.556 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -59.96 -41.05 91.08 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.438 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.427 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 75.5 t -64.09 -46.51 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 77.8 t -63.72 -47.26 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.656 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.24 -38.94 92.86 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.417 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.427 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 47.6 m-85 -70.81 -36.53 73.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.71 0.29 . . . . 0.0 111.749 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.3 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.312 -0.852 . . . . 0.0 111.133 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.44 154.35 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 12.84 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 110.754 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -125.64 146.65 49.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -85.09 87.85 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.45 140.87 51.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.486 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 99.7 m -99.06 159.15 15.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.241 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -61.86 -39.89 93.47 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.308 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.3 m -88.77 127.16 35.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.8 pt -104.01 -9.55 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -147.93 137.57 22.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.142 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.8 p -129.64 160.24 33.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 9.2 t80 -101.93 117.57 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -93.44 -12.44 29.77 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.407 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 35.4 mmtp -84.61 122.78 74.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.77 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.502 ' HA ' ' CD2' ' A' ' 57' ' ' TRP . 74.4 Cg_exo -54.67 129.39 34.75 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.455 2.104 . . . . 0.0 112.794 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -160.93 137.17 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -119.4 90.64 42.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.78 124.38 11.83 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.556 2.171 . . . . 0.0 112.178 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -83.72 0.54 46.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.788 0.328 . . . . 0.0 111.452 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.83 14.22 29.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -75.22 119.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.938 0.399 . . . . 0.0 110.073 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -102.51 -42.96 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -130.41 149.69 51.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 111.478 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 65.9 tp -118.52 122.03 41.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.375 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -109.48 143.73 38.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.807 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.7 128.97 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.376 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.5 mt -104.43 123.24 58.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 -179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.45 139.36 47.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.9 p -71.19 -42.14 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.83 -170.51 36.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.591 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.43 -22.64 15.94 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.065 1.844 . . . . 0.0 112.316 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -71.14 -39.8 71.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' SER . 71.3 m -116.67 131.23 57.0 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.39 95.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.217 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -111.33 158.27 19.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.003 0.43 . . . . 0.0 111.783 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.8 p -83.11 166.38 18.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.465 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.486 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.5 mt-10 -125.24 143.44 50.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 110.986 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -117.49 127.92 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.997 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.405 HG13 ' O ' ' A' ' 49' ' ' LEU . 16.5 tt -127.32 137.66 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.168 0.508 . . . . 0.0 110.537 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 27.3 m -112.73 148.4 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.973 0.416 . . . . 0.0 110.745 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.66 123.14 48.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.75 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.99 153.92 20.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.5 p -60.07 -19.5 53.39 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.597 0.561 . . . . 0.0 112.17 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 3.98 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.93 56.72 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.233 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -101.46 139.19 37.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.872 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -117.44 129.29 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.672 0.272 . . . . 0.0 110.866 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' O ' HG13 ' A' ' 40' ' ' ILE . 87.7 mt -120.51 135.9 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.629 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.86 123.95 46.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -117.29 148.04 42.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -87.72 118.4 69.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.134 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.56 -19.34 64.36 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.171 2.581 . . . . 0.0 113.853 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.18 -21.24 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.83 133.59 35.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.007 0.432 . . . . 0.0 111.02 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.35 -40.51 96.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . 0.502 ' CD2' ' HA ' ' A' ' 16' ' ' PRO . 56.7 p-90 -64.0 -30.35 71.43 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.644 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.17 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.043 0.449 . . . . 0.0 109.927 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.96 -40.0 91.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.317 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -63.05 -38.34 90.8 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.553 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.586 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 66.4 t -59.81 -47.57 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.377 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.06 -38.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.54 -44.63 77.87 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.65 -41.6 96.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.586 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 41.0 m-85 -70.9 -34.88 72.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 111.577 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.679 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.946 0.403 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.96 150.84 35.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.783 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -90.97 1.3 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -90.02 2.83 54.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.069 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 30' ' ' SER . 60.8 tp -79.06 119.29 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.685 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -146.51 147.54 31.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.238 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.513 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 8.5 m -76.31 93.6 3.47 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.72 0.295 . . . . 0.0 110.353 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -63.37 -41.14 98.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.082 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.7 m -93.28 93.13 8.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.72 -44.34 98.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -116.43 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -130.12 158.46 39.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.413 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.407 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t80 -108.48 138.74 44.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.648 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 71.0 m -61.71 -41.45 97.62 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -131.8 72.84 79.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.2 Cg_endo -72.07 156.23 56.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.752 2.302 . . . . 0.0 113.358 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.47 131.01 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.843 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -100.83 107.43 49.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.656 0.265 . . . . 0.0 110.79 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.58 153.51 34.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.932 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.28 3.25 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.402 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -98.12 20.2 12.79 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.83 118.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -91.75 -45.74 8.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.72 149.07 52.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.779 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.6 tt -124.88 114.7 19.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.457 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -107.33 136.39 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.206 0.527 . . . . 0.0 111.482 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -117.35 127.74 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.954 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -108.49 121.39 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 110.719 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.22 144.28 50.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.83 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' HD23 ' A' ' 5' ' ' LEU . 2.8 p -72.17 -54.48 9.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.68 -165.09 25.1 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.113 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.93 -29.14 8.68 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.676 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -71.48 -38.38 71.24 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 t -113.53 128.46 56.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.742 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.58 93.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -127.31 139.97 52.52 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -64.72 137.64 57.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.595 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.513 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.2 mt-10 -125.56 140.9 52.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 130.73 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.5 tt -128.58 141.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.4 m -114.57 149.46 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 111.042 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -110.6 122.34 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.178 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.0 mt -90.27 153.17 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.7 p -60.57 -19.88 58.82 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.69 0.619 . . . . 0.0 112.124 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -85.13 4.22 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.94 58.93 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.324 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 96.5 mtt-85 -101.26 158.81 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.545 -178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -128.1 133.33 49.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.4 mt -123.9 142.54 51.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.215 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.8 m -100.12 133.14 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.71 148.34 39.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -98.64 110.41 56.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.49 -14.3 36.73 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.086 2.524 . . . . 0.0 113.54 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -61.68 -37.08 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.648 ' HG3' ' O ' ' A' ' 14' ' ' SER . 77.5 mm-40 -77.29 127.88 33.37 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.84 -40.34 97.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -64.52 -32.8 74.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.87 -43.23 97.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -61.22 -41.41 96.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.51 -46.0 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.601 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.65 -49.2 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.77 -43.06 89.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.0 -40.04 83.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.978 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -62.37 -48.59 79.08 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.943 -179.521 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.979 0.418 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.32 156.61 42.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.95 17.06 24.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.427 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -110.34 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.14 77.51 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -146.5 138.97 25.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.5 m -86.19 145.57 26.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -62.27 -40.86 97.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.066 0.46 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.2 m -105.99 105.46 15.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -63.24 -47.2 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.845 -179.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.4 mttp -132.21 149.01 52.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 111.303 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 p -129.8 156.92 43.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.128 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.42 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 35.9 t80 -108.7 142.46 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.6 p -62.04 -35.64 79.21 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.58 73.53 80.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.505 0.193 . . . . 0.0 110.964 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.31 156.74 54.57 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.652 2.235 . . . . 0.0 113.159 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -86.88 143.54 27.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.105 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -119.06 90.95 42.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.268 -179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.22 147.74 94.47 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.195 2.597 . . . . 0.0 112.582 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -81.06 3.27 23.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -96.52 16.37 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.892 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.1 mt -76.06 118.38 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.74 -44.34 8.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -130.62 149.18 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.4 tt -124.42 115.91 21.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -108.31 132.23 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.32 0.581 . . . . 0.0 112.046 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.8 t -122.49 128.47 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.381 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.1 148.63 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.105 0.479 . . . . 0.0 111.776 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.95 148.95 36.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.084 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 79.5 p -70.59 -40.56 73.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.713 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.88 -156.62 36.27 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.922 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.87 -20.09 7.91 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.167 1.911 . . . . 0.0 112.217 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -70.76 -40.18 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.498 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 30' ' ' SER . 97.6 m -124.48 149.08 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.67 -4.58 55.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.05 139.9 41.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 111.6 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.6 m -64.62 137.41 57.82 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.083 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.99 132.89 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 111.753 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -117.53 130.28 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.9 tt -132.15 144.18 37.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 110.896 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.7 m -115.16 149.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.759 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -114.37 119.54 37.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.423 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.63 153.18 20.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.0 p -60.53 -20.13 59.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.063 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.52 4.09 37.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.839 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.11 22.46 57.25 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.22 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -100.89 144.15 30.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.318 . . . . 0.0 111.118 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -121.29 130.28 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.995 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.4 141.7 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 87.5 m -97.06 134.64 40.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.392 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.28 144.15 44.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.778 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -96.55 116.51 66.16 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.06 -13.25 39.17 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.291 2.66 . . . . 0.0 113.946 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.52 -38.43 87.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -79.63 127.66 32.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.751 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -69.19 -35.62 76.45 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -65.21 -31.81 73.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.635 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.6 -42.11 94.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -61.78 -38.24 87.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.59 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -60.48 -41.31 93.97 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.888 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 78.8 t -65.1 -44.33 95.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.292 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -61.47 -47.13 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.843 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.45 -39.58 94.1 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.357 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.24 -46.03 92.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.284 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -68.1 -38.15 81.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.436 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.171 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HA ' ' OE2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.58 -41.13 98.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.586 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.4 m -93.58 87.95 5.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.27 -43.94 98.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.255 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -121.42 149.09 43.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.27 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -127.28 158.63 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.77 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -89.82 117.96 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.2 p -94.94 -19.71 20.01 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.02 129.73 82.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 110.579 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.26 129.05 33.14 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.46 2.107 . . . . 0.0 112.916 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -160.06 125.17 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.506 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -122.51 89.31 49.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.284 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.91 134.55 13.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.223 1.949 . . . . 0.0 112.577 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.72 3.14 23.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.725 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -94.06 8.5 41.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -82.16 119.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.264 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -108.17 -34.95 6.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.031 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -140.0 159.55 41.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.244 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 144.29 29.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 110.296 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -119.74 145.01 46.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.07 126.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.535 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.19 124.82 66.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 110.709 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.32 129.53 39.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.92 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 3.6 p -72.98 -53.17 11.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.152 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.15 -165.65 42.35 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.19 -34.98 87.82 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.039 2.493 . . . . 0.0 113.259 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -64.78 -40.53 95.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 30' ' ' SER . 94.8 m -118.1 124.68 48.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.278 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.07 96.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.37 142.34 36.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.3 m -67.81 138.28 56.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.865 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' HA ' ' A' ' 7' ' ' CYS . 46.5 mt-10 -104.48 125.47 50.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.42 128.66 75.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 48' ' ' GLU . 21.2 tt -132.38 141.58 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.077 0.465 . . . . 0.0 110.867 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.17 151.54 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.777 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -113.56 122.59 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.665 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -91.4 153.54 19.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -21.93 62.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.304 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.49 10.47 12.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 25.88 64.3 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -101.62 145.72 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -117.83 135.08 54.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.745 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.0 tp -128.41 128.19 43.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.83 129.82 37.72 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.945 0.403 . . . . 0.0 110.397 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.3 mt -116.37 145.84 42.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.953 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -92.22 118.75 68.28 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.164 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.67 -20.63 69.66 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.119 2.546 . . . . 0.0 113.936 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -68.91 -20.99 64.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.592 0.234 . . . . 0.0 111.608 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.28 132.55 35.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 111.083 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.91 -42.76 99.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.182 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -62.36 -29.96 70.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.8 -42.71 96.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 109.895 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -61.72 -38.68 88.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.725 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -61.47 -40.14 93.46 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.288 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.482 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.8 t -61.27 -48.65 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.335 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.67 -48.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.694 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.92 -46.94 79.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.72 -41.69 91.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 33.0 m-85 -71.31 -36.3 71.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.663 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.051 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.48 -41.06 96.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.573 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.2 m -97.56 127.21 43.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.61 -27.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 111.133 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -133.79 143.21 48.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -132.13 158.8 40.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.896 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -108.86 143.51 37.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.388 . . . . 0.0 110.946 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.4 p -90.6 -11.01 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.652 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -78.95 124.46 84.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.91 133.66 59.38 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.874 2.382 . . . . 0.0 113.191 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -154.6 111.62 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -136.33 89.03 19.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.792 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.65 142.36 94.1 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.759 2.306 . . . . 0.0 112.379 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -81.67 2.55 29.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.037 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.61 14.7 27.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.74 119.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -89.53 -48.73 7.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.78 150.48 49.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.155 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.3 tt -119.18 116.6 26.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.184 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -106.68 144.62 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.406 0.622 . . . . 0.0 112.011 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.9 t -115.58 128.79 72.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.613 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.9 mt -106.29 127.0 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.874 0.368 . . . . 0.0 111.08 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.12 142.26 57.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 78.5 p -70.74 -41.49 71.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.0 -174.34 43.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.533 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.79 -31.32 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.042 1.828 . . . . 0.0 112.986 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.72 -38.56 70.49 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 30' ' ' SER . 79.0 m -105.58 119.44 39.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.76 94.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.068 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -106.62 146.36 30.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.625 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -74.01 162.91 28.54 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.589 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -125.55 137.73 53.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.9 mt -117.67 128.69 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.4 tt -129.98 138.0 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.207 0.527 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.9 m -114.74 148.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.83 121.96 46.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 47' ' ' ARG . 87.0 mt -87.57 152.45 22.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -59.78 -24.93 64.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.878 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -80.43 7.58 9.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.139 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.01 63.24 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.648 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB2' HD12 ' A' ' 43' ' ' LEU . 57.5 mmm-85 -101.76 147.45 26.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.1 mt-10 -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.864 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 87.9 mt -120.96 145.43 47.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.676 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -105.07 128.67 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.116 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.22 142.1 47.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.1 t0 -92.9 116.3 66.28 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 28.8 Cg_endo -61.61 -18.89 62.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.071 2.514 . . . . 0.0 113.835 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -68.1 -21.66 64.94 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 0.0 111.565 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 58' ' ' VAL . 76.6 mm-40 -84.66 132.43 34.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.15 -40.24 95.32 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.086 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' VAL . 68.5 p-90 -63.19 -30.69 71.79 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 55' ' ' GLU . 53.4 t -63.46 -43.69 98.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.413 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.97 -42.11 97.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -62.76 -41.13 99.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.314 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 57' ' ' TRP . 64.4 t -63.17 -46.63 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.36 -47.51 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.211 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -40.97 91.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.613 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -62.3 -49.08 77.05 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.869 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 48.8 m-85 -71.57 -37.12 71.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.476 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.244 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -64.62 -40.1 94.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.685 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.6 m -92.97 87.32 5.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.4 mt -63.25 -44.96 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 110.227 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 10' ' ' ILE . 68.8 mttm -127.66 147.75 50.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.943 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -128.15 158.84 36.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.8 158.35 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.3 p -91.06 -3.43 57.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -127.51 73.25 77.98 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.681 0.277 . . . . 0.0 111.6 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 161.79 34.3 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.973 2.449 . . . . 0.0 113.319 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.23 130.04 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.488 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 61' ' ' VAL . 66.5 m80 -112.88 98.05 43.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.08 155.25 33.47 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 112.615 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -80.07 3.66 19.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.502 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -96.62 17.54 16.17 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.58 121.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.04 -47.49 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.913 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.07 147.42 52.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.55 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt -119.53 112.51 19.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.893 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -110.19 147.55 33.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.0 111.375 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -126.96 150.67 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.607 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.3 mt -119.86 124.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.612 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.75 138.99 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p -72.16 -55.12 7.8 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.814 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.16 -154.22 20.13 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.113 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.5 -25.69 3.63 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.233 1.955 . . . . 0.0 112.772 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -71.08 -40.19 71.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 74.6 m -113.46 131.7 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.34 92.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -131.14 149.29 52.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 111.782 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 59.2 m -64.05 138.57 58.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.984 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -116.94 139.76 50.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 0.0 111.677 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -118.34 129.97 73.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 48' ' ' GLU . 17.7 tt -131.66 135.9 58.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.55 HG12 ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -112.98 149.12 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.86 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.89 123.2 49.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.94 154.79 20.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.3 p -60.04 -19.64 53.88 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.567 0.542 . . . . 0.0 112.131 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.52 5.27 36.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.008 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.49 23.15 57.16 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -99.75 148.08 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.649 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.3 mt-10 -118.83 131.8 56.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 88.9 mt -120.67 143.89 48.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.669 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 t -98.75 128.45 44.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.094 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -115.61 143.31 45.54 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.408 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -95.87 113.97 63.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG3' ' O ' ' A' ' 37' ' ' THR . 54.4 Cg_endo -67.78 -15.87 45.0 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 113.638 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.74 -37.66 85.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.398 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -74.17 126.22 30.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.692 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -62.78 -41.37 99.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.52 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -63.19 -30.47 71.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.366 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.1 -44.5 99.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.067 0.46 . . . . 0.0 109.768 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -62.11 -39.24 91.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -60.9 -42.28 97.73 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG11 ' CG ' ' A' ' 18' ' ' HIS . 74.6 t -66.83 -44.57 88.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.88 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.93 -48.17 89.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.392 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.16 -41.13 95.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -63.65 -43.66 96.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.937 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.33 -47.02 87.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.062 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.105 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.231 0.121 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.75 -39.97 94.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.113 0.482 . . . . 0.0 111.534 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.9 m -93.21 92.47 7.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.411 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.3 mt -63.69 -45.02 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.219 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' A' ' 10' ' ' ILE . 58.6 mtmt -128.18 148.52 50.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -128.46 158.92 37.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.033 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 47.1 t80 -108.15 142.4 38.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.992 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 80.7 p -62.18 -36.34 81.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.05 71.64 81.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 O-C-N 122.175 -0.328 . . . . 0.0 111.776 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.94 156.23 52.54 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.446 2.097 . . . . 0.0 112.55 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -87.79 119.92 28.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.459 ' NE2' HD13 ' A' ' 22' ' ' ILE . 22.2 t-160 -116.24 100.72 53.7 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.15 139.64 79.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.005 2.47 . . . . 0.0 112.448 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.13 0.56 40.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.452 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.58 17.83 20.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.522 HG22 HD22 ' A' ' 43' ' ' LEU . 39.6 pt -66.83 147.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.57 -29.81 12.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.458 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -139.39 148.49 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.224 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.8 tt -128.99 106.85 9.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.642 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HB3' HG23 ' A' ' 40' ' ' ILE . 32.4 tpt180 -100.24 128.05 46.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.236 0.541 . . . . 0.0 111.477 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.68 125.72 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.53 124.59 71.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.116 0.484 . . . . 0.0 111.635 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.14 154.86 30.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 37' ' ' THR . 77.6 p -70.43 -42.91 70.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.794 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.98 -162.12 31.94 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.38 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -16.18 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.727 2.285 . . . . 0.0 114.222 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -104.79 -2.07 25.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 41.3 t -127.73 132.75 49.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.81 93.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.85 156.47 45.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 30' ' ' SER . 74.5 p -74.33 161.9 29.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.547 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -149.69 149.55 30.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.702 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.76 129.05 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.662 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.2 tt -128.49 137.25 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 0.0 110.645 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.765 HG12 ' HG ' ' A' ' 25' ' ' LEU . 26.8 m -115.42 152.68 17.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -118.74 123.53 45.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 22' ' ' ILE . 2.3 mm? -87.41 157.95 19.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.142 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.6 p -59.95 -21.19 60.87 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.655 0.597 . . . . 0.0 112.453 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.0 6.7 34.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.92 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.61 58.96 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.082 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -99.0 128.33 45.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.662 ' HB3' HD11 ' A' ' 40' ' ' ILE . 99.9 mt-10 -104.74 130.64 52.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 111.043 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -119.4 144.48 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.097 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.75 127.9 47.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.3 mt -112.51 145.52 40.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.76 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.23 114.59 59.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.09 -17.96 40.37 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.966 2.444 . . . . 0.0 113.438 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -70.19 -21.43 63.04 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 14' ' ' SER . 81.1 mm-40 -85.7 126.37 33.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.88 -40.52 97.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.652 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -63.33 -34.11 76.99 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.295 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.86 -44.41 96.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.144 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -62.23 -39.87 94.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.069 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -61.2 -41.63 97.17 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.45 -44.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.23 -47.43 93.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.16 -39.78 94.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.64 -44.98 95.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.853 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.27 -39.21 86.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.176 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -67.81 -23.19 65.16 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.9 m -97.89 85.01 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.739 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.56 -45.39 85.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.498 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -130.24 145.05 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.216 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.6 p -130.58 158.99 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -92.47 140.61 29.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.3 m -61.01 -39.6 90.35 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.04 76.12 76.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.565 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.83 158.93 51.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.73 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.18 140.23 33.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.423 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -111.6 99.98 46.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.09 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.04 145.92 96.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.079 2.519 . . . . 0.0 112.644 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -80.01 3.17 20.99 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.202 0.525 . . . . 0.0 110.821 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.18 20.88 12.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.195 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 65' ' ' PHE . 83.9 mt -75.72 120.41 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.778 0.323 . . . . 0.0 110.152 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -89.02 -47.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -133.86 149.18 51.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -120.55 115.21 22.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HB2' HG23 ' A' ' 40' ' ' ILE . 41.1 mmt180 -104.97 142.8 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.203 0.525 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.75 128.44 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.93 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.6 mt -108.42 123.88 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.41 146.49 46.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.8 p -70.79 -42.81 69.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.08 -162.73 26.93 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.735 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.35 -24.91 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.038 1.825 . . . . 0.0 112.385 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -39.41 70.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 30' ' ' SER . 83.3 m -113.9 131.15 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.73 0.3 . . . . 0.0 111.618 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.0 95.91 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.816 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -118.56 159.04 24.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.316 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.6 p -79.45 164.5 23.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.08 139.62 51.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 111.245 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.68 127.56 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.6 tt -129.66 138.22 54.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.289 0.566 . . . . 0.0 111.119 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.51 HG12 ' HG ' ' A' ' 25' ' ' LEU . 29.3 m -115.05 147.33 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.491 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -109.45 117.51 34.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' ARG . 87.8 mt -86.34 153.7 21.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.281 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m -57.04 -34.24 68.03 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.821 0.7 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.57 6.78 3.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.615 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.69 22.98 60.87 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.666 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HB3' HD12 ' A' ' 43' ' ' LEU . 41.4 ttm180 -101.11 142.19 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.061 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -116.34 131.65 56.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.881 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.7 mt -121.36 146.05 47.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.1 t -102.92 126.3 50.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -109.57 145.35 36.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.731 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -90.11 114.46 60.98 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.06 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.81 -16.76 41.92 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.048 2.499 . . . . 0.0 113.318 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -62.12 -37.23 84.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.24 121.76 23.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.772 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -63.93 -31.66 72.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.315 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.09 -43.85 99.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.41 -38.85 91.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.97 -42.09 97.65 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.43 -44.37 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.94 -47.25 94.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 98.7 mt-10 -64.58 -41.45 96.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.836 0.351 . . . . 0.0 110.539 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.01 -43.93 94.16 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 22' ' ' ILE . 77.7 t80 -61.33 -46.89 88.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 29.3 mt . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.48 -39.57 94.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.413 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.92 98.9 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.16 -43.46 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.319 0.58 . . . . 0.0 109.888 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -124.29 152.77 42.65 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 70.1 p -126.36 158.5 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 11.6 t80 -81.3 118.39 22.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.781 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -98.66 -15.18 19.51 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 60.3 mtpt -72.38 131.01 85.25 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.496 0.188 . . . . 0.0 110.951 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.77 71.7 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.255 2.636 . . . . 0.0 113.863 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -118.8 127.11 53.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.625 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -111.26 99.15 42.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.82 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.72 129.37 10.78 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.176 1.917 . . . . 0.0 112.752 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -81.09 3.25 23.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.565 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.8 15.42 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -77.87 95.64 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -71.67 -42.77 67.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.51 149.6 49.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.149 0.499 . . . . 0.0 111.53 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.59 HD13 HG12 ' A' ' 41' ' ' VAL . 58.5 tp -119.29 120.92 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.03 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 40' ' ' ILE . 85.0 mtp180 -109.9 139.58 44.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -116.83 126.68 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.787 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.08 122.42 21.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 9.4 p -72.51 -43.47 63.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.581 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.37 48.36 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.139 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.27 -25.63 26.03 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.318 2.012 . . . . 0.0 112.83 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.07 -40.3 87.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 30' ' ' SER . 92.0 m -117.3 119.77 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.714 0.292 . . . . 0.0 110.609 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.69 95.3 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -98.31 131.03 44.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.3 m -63.66 139.01 58.73 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.118 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.05 127.9 51.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.094 0.473 . . . . 0.0 112.227 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.35 129.09 75.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -131.34 138.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.253 0.549 . . . . 0.0 110.995 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 25' ' ' LEU . 31.2 m -112.81 149.76 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -116.31 120.02 37.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.27 153.62 23.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.665 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.5 p -59.7 -21.1 60.15 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.49 0.494 . . . . 0.0 112.122 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.52 7.27 17.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 110.91 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.2 20.62 66.82 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -101.78 127.55 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.647 0.26 . . . . 0.0 110.899 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -104.45 129.61 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.363 . . . . 0.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.66 140.68 49.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.22 131.86 44.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD22 ' CH2' ' A' ' 57' ' ' TRP . 82.0 mt -117.0 145.93 43.36 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.196 0.522 . . . . 0.0 111.691 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 45.1 t0 -97.1 117.12 66.05 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.35 -18.58 53.76 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 123.222 2.615 . . . . 0.0 113.913 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.26 -24.23 66.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 58' ' ' VAL . 77.1 mm-40 -81.87 135.12 35.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.062 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.04 -42.07 98.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.421 ' CH2' HD22 ' A' ' 51' ' ' LEU . 61.4 p-90 -62.87 -29.65 70.92 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 55' ' ' GLU . 57.8 t -64.45 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.71 -38.5 85.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.59 -39.37 90.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.199 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.6 t -61.0 -47.83 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.351 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG23 HD21 ' A' ' 25' ' ' LEU . 15.0 p -72.4 -41.96 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.02 -42.87 79.97 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.28 -41.6 73.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 32.0 m-85 -71.37 -37.19 71.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.023 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.168 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.8 m -90.28 95.91 10.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.912 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -83.79 -27.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.569 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -130.07 143.66 50.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.431 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 52' ' ' ASP . 72.1 p -131.41 159.57 37.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 111.746 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.85 128.75 55.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -64.25 -37.27 86.88 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -128.36 72.77 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.65 159.56 48.46 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.493 2.129 . . . . 0.0 111.85 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 20.5 p90 -76.27 168.26 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -109.62 98.34 32.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.403 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 17' ' ' PHE . 3.2 Cg_exo -81.91 124.11 4.34 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.959 2.439 . . . . 0.0 112.479 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.14 -1.05 51.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.45 20.78 13.17 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.94 120.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.148 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -101.85 -35.8 8.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.532 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -132.14 144.35 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.728 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -127.02 110.79 13.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.24 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 40' ' ' ILE . 82.6 mtt85 -101.5 137.47 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.0 111.456 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -117.46 129.08 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.064 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.85 124.02 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.16 147.71 48.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 p -71.66 -53.01 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.5 -159.98 29.22 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.738 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.06 -24.13 4.11 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.043 1.829 . . . . 0.0 112.288 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -73.06 -39.96 65.46 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.85 131.84 55.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.754 0.311 . . . . 0.0 111.053 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.66 93.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.139 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -129.35 158.1 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.849 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.4 p -71.5 158.11 36.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.654 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -129.69 139.61 51.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.929 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 62' ' ' VAL . 87.3 mt -120.8 129.63 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.118 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.9 tt -128.73 135.64 61.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.05 0.452 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.1 m -112.78 148.08 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.0 110.765 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.37 124.14 49.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.855 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.01 159.3 17.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.731 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.3 p -59.56 -21.21 59.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.415 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.34 5.2 35.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.075 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 25.85 54.53 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.026 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -101.07 142.45 32.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.678 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -116.04 131.38 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 110.823 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -120.44 145.19 47.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.55 126.34 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 58' ' ' VAL . 84.7 mt -116.91 145.23 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' HB ' ' A' ' 12' ' ' THR . 45.4 t0 -108.59 113.74 59.64 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.72 -12.93 33.88 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.652 2.901 . . . . 0.0 115.514 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.04 -21.43 66.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.142 0.428 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -95.86 135.61 37.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.718 0.294 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 26.9 m120 -62.3 -39.03 91.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.503 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.44 -45.03 92.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.159 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 51' ' ' LEU . 63.4 t -62.52 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -61.41 -38.22 86.33 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.556 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 56' ' ' ASN . 27.4 mmm180 -59.96 -41.05 91.08 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.438 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 75.5 t -64.09 -46.51 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 77.8 t -63.72 -47.26 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.656 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.24 -38.94 92.86 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.417 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 47.6 m-85 -70.81 -36.53 73.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.71 0.29 . . . . 0.0 111.749 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 25' ' ' LEU . 88.3 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.312 -0.852 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 99.7 m . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.692 0.282 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -61.86 -39.89 93.47 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.308 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.3 m -88.77 127.16 35.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.8 pt -104.01 -9.55 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -147.93 137.57 22.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.142 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.8 p -129.64 160.24 33.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 9.2 t80 -101.93 117.57 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -93.44 -12.44 29.77 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 35.4 mmtp -84.61 122.78 74.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.77 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HA ' ' CD2' ' A' ' 57' ' ' TRP . 74.4 Cg_exo -54.67 129.39 34.75 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.455 2.104 . . . . 0.0 112.794 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -160.93 137.17 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -119.4 90.64 42.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.78 124.38 11.83 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.556 2.171 . . . . 0.0 112.178 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -83.72 0.54 46.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.788 0.328 . . . . 0.0 111.452 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.83 14.22 29.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -75.22 119.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.938 0.399 . . . . 0.0 110.073 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -102.51 -42.96 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -130.41 149.69 51.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 111.478 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD13 HG12 ' A' ' 41' ' ' VAL . 65.9 tp -118.52 122.03 41.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.375 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' A' ' 40' ' ' ILE . 99.7 mtt180 -109.48 143.73 38.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.807 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.7 128.97 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.376 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 81.5 mt -104.43 123.24 58.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.45 139.36 47.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.9 p -71.19 -42.14 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.83 -170.51 36.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.591 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.43 -22.64 15.94 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.065 1.844 . . . . 0.0 112.316 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -71.14 -39.8 71.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' SER . 71.3 m -116.67 131.23 57.0 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.39 95.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.217 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -111.33 158.27 19.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.003 0.43 . . . . 0.0 111.783 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.8 p -83.11 166.38 18.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.465 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.5 mt-10 -125.24 143.44 50.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 110.986 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -117.49 127.92 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.997 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.5 tt -127.32 137.66 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.168 0.508 . . . . 0.0 110.537 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 25' ' ' LEU . 27.3 m -112.73 148.4 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.973 0.416 . . . . 0.0 110.745 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.66 123.14 48.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.75 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.99 153.92 20.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.5 p -60.07 -19.5 53.39 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.597 0.561 . . . . 0.0 112.17 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 3.98 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.93 56.72 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.233 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -101.46 139.19 37.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.872 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -117.44 129.29 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.672 0.272 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.421 ' O ' HG13 ' A' ' 40' ' ' ILE . 87.7 mt -120.51 135.9 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.629 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.86 123.95 46.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -117.29 148.04 42.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -87.72 118.4 69.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.134 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.56 -19.34 64.36 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.171 2.581 . . . . 0.0 113.853 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.18 -21.24 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.83 133.59 35.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.007 0.432 . . . . 0.0 111.02 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.35 -40.51 96.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . 0.49 ' CD2' ' HA ' ' A' ' 16' ' ' PRO . 56.7 p-90 -64.0 -30.35 71.43 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.644 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.17 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.043 0.449 . . . . 0.0 109.927 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.96 -40.0 91.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.317 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -63.05 -38.34 90.8 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.553 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.582 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 66.4 t -59.81 -47.57 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.377 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.06 -38.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.54 -44.63 77.87 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.65 -41.6 96.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 41.0 m-85 -70.9 -34.88 72.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 111.577 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.679 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 8.5 m . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.72 0.295 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -63.37 -41.14 98.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.082 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.7 m -93.28 93.13 8.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.72 -44.34 98.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -116.43 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -130.12 158.46 39.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.413 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t80 -108.48 138.74 44.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 71.0 m -61.71 -41.45 97.62 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -131.8 72.84 79.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.2 Cg_endo -72.07 156.23 56.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.752 2.302 . . . . 0.0 113.358 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.47 131.01 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.843 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -100.83 107.43 49.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.656 0.265 . . . . 0.0 110.79 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.58 153.51 34.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.932 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.28 3.25 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.402 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -98.12 20.2 12.79 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.83 118.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -91.75 -45.74 8.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.72 149.07 52.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.779 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.6 tt -124.88 114.7 19.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.457 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -107.33 136.39 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.206 0.527 . . . . 0.0 111.482 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -117.35 127.74 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.954 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -108.49 121.39 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 110.719 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.22 144.28 50.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.83 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -72.17 -54.48 9.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.68 -165.09 25.1 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.113 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.93 -29.14 8.68 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.676 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -71.48 -38.38 71.24 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 t -113.53 128.46 56.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.742 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.58 93.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -127.31 139.97 52.52 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -64.72 137.64 57.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.595 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.2 mt-10 -125.56 140.9 52.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 130.73 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 48' ' ' GLU . 20.5 tt -128.58 141.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.4 m -114.57 149.46 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 111.042 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -110.6 122.34 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.178 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 47' ' ' ARG . 82.0 mt -90.27 153.17 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.7 p -60.57 -19.88 58.82 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.69 0.619 . . . . 0.0 112.124 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -85.13 4.22 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.94 58.93 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.324 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB2' HD12 ' A' ' 43' ' ' LEU . 96.5 mtt-85 -101.26 158.81 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.545 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.3 mt-10 -128.1 133.33 49.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.4 mt -123.9 142.54 51.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.215 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.8 m -100.12 133.14 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.71 148.34 39.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -98.64 110.41 56.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.49 -14.3 36.73 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.086 2.524 . . . . 0.0 113.54 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -61.68 -37.08 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 14' ' ' SER . 77.5 mm-40 -77.29 127.88 33.37 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.84 -40.34 97.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -64.52 -32.8 74.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.87 -43.23 97.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -61.22 -41.41 96.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.51 -46.0 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.601 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.65 -49.2 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.77 -43.06 89.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.0 -40.04 83.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.978 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -62.37 -48.59 79.08 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.943 -179.521 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.5 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.5 0.19 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -62.27 -40.86 97.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.066 0.46 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.2 m -105.99 105.46 15.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.1 mt -63.24 -47.2 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.845 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.631 ' HG3' HG22 ' A' ' 10' ' ' ILE . 64.4 mttp -132.21 149.01 52.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 111.303 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 p -129.8 156.92 43.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.128 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 35.9 t80 -108.7 142.46 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.6 p -62.04 -35.64 79.21 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.58 73.53 80.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.505 0.193 . . . . 0.0 110.964 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.31 156.74 54.57 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.652 2.235 . . . . 0.0 113.159 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -86.88 143.54 27.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.105 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.535 ' CG ' HG11 ' A' ' 61' ' ' VAL . 66.5 m80 -119.06 90.95 42.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.22 147.74 94.47 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.195 2.597 . . . . 0.0 112.582 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -81.06 3.27 23.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -96.52 16.37 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.892 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.1 mt -76.06 118.38 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.74 -44.34 8.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -130.62 149.18 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.4 tt -124.42 115.91 21.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -108.31 132.23 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.32 0.581 . . . . 0.0 112.046 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.8 t -122.49 128.47 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.381 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.1 148.63 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.105 0.479 . . . . 0.0 111.776 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.95 148.95 36.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.084 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 79.5 p -70.59 -40.56 73.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.713 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.88 -156.62 36.27 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.922 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.87 -20.09 7.91 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.167 1.911 . . . . 0.0 112.217 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -70.76 -40.18 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.498 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' SER . 97.6 m -124.48 149.08 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.67 -4.58 55.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.05 139.9 41.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 111.6 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.6 m -64.62 137.41 57.82 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.083 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.99 132.89 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 111.753 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -117.53 130.28 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -132.15 144.18 37.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 110.896 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.7 m -115.16 149.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.759 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -114.37 119.54 37.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.423 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.63 153.18 20.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.0 p -60.53 -20.13 59.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.063 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.52 4.09 37.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.839 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.11 22.46 57.25 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.22 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -100.89 144.15 30.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.318 . . . . 0.0 111.118 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.6 mt-10 -121.29 130.28 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.4 141.7 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 87.5 m -97.06 134.64 40.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.392 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.28 144.15 44.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.778 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -96.55 116.51 66.16 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.06 -13.25 39.17 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.291 2.66 . . . . 0.0 113.946 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.52 -38.43 87.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -79.63 127.66 32.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.751 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -69.19 -35.62 76.45 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -65.21 -31.81 73.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.635 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.6 -42.11 94.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -61.78 -38.24 87.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.59 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -60.48 -41.31 93.97 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.888 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.535 HG11 ' CG ' ' A' ' 18' ' ' HIS . 78.8 t -65.1 -44.33 95.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.292 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -61.47 -47.13 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.843 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.45 -39.58 94.1 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.357 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.24 -46.03 92.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.284 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -68.1 -38.15 81.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.436 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.171 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.61 153.12 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.95 17.51 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -26.7 68.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.475 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.79 139.48 55.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.5 140.69 22.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.566 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HA ' ' OE2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -88.06 80.2 7.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.58 -41.13 98.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.586 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.4 m -93.58 87.95 5.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.27 -43.94 98.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.255 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -121.42 149.09 43.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.27 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -127.28 158.63 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.77 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -89.82 117.96 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.2 p -94.94 -19.71 20.01 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.02 129.73 82.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 110.579 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.26 129.05 33.14 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.46 2.107 . . . . 0.0 112.916 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -160.06 125.17 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.506 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -122.51 89.31 49.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.284 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.91 134.55 13.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.223 1.949 . . . . 0.0 112.577 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.72 3.14 23.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.725 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -94.06 8.5 41.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -82.16 119.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.264 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -108.17 -34.95 6.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.031 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -140.0 159.55 41.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.244 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 144.29 29.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 110.296 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -119.74 145.01 46.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.07 126.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.535 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.19 124.82 66.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 110.709 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.32 129.53 39.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.92 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 3.6 p -72.98 -53.17 11.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.152 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.15 -165.65 42.35 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.19 -34.98 87.82 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.039 2.493 . . . . 0.0 113.259 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -64.78 -40.53 95.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 30' ' ' SER . 94.8 m -118.1 124.68 48.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.278 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.07 96.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.37 142.34 36.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.3 m -67.81 138.28 56.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.865 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' HA ' ' A' ' 7' ' ' CYS . 46.5 mt-10 -104.48 125.47 50.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.42 128.66 75.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 48' ' ' GLU . 21.2 tt -132.38 141.58 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.077 0.465 . . . . 0.0 110.867 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.17 151.54 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.777 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -113.56 122.59 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.665 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -91.4 153.54 19.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -21.93 62.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.304 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.49 10.47 12.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 25.88 64.3 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -101.62 145.72 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -117.83 135.08 54.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.745 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.0 tp -128.41 128.19 43.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.83 129.82 37.72 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.945 0.403 . . . . 0.0 110.397 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.3 mt -116.37 145.84 42.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.953 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -92.22 118.75 68.28 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.164 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.67 -20.63 69.66 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.119 2.546 . . . . 0.0 113.936 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -68.91 -20.99 64.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.592 0.234 . . . . 0.0 111.608 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.28 132.55 35.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 111.083 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.91 -42.76 99.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.182 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -62.36 -29.96 70.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.8 -42.71 96.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 109.895 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -61.72 -38.68 88.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.725 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -61.47 -40.14 93.46 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.288 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.482 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.8 t -61.27 -48.65 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.335 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.67 -48.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.694 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.92 -46.94 79.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.72 -41.69 91.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 33.0 m-85 -71.31 -36.3 71.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.663 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.051 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.963 0.411 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.94 153.85 39.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.691 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.39 11.63 27.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.24 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.92 -37.09 85.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.555 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.9 120.46 13.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.116 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -131.86 159.07 39.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.176 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.6 m -74.11 123.75 25.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.48 -41.06 96.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.573 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.2 m -97.56 127.21 43.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.61 -27.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 111.133 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -133.79 143.21 48.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -132.13 158.8 40.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.896 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -108.86 143.51 37.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.388 . . . . 0.0 110.946 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.4 p -90.6 -11.01 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.652 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -78.95 124.46 84.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.91 133.66 59.38 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.874 2.382 . . . . 0.0 113.191 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -154.6 111.62 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -136.33 89.03 19.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.792 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.65 142.36 94.1 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.759 2.306 . . . . 0.0 112.379 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -81.67 2.55 29.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.037 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.61 14.7 27.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.74 119.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -89.53 -48.73 7.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.78 150.48 49.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.155 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.3 tt -119.18 116.6 26.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.184 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -106.68 144.62 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.406 0.622 . . . . 0.0 112.011 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.9 t -115.58 128.79 72.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.613 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.9 mt -106.29 127.0 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.874 0.368 . . . . 0.0 111.08 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.12 142.26 57.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 78.5 p -70.74 -41.49 71.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.0 -174.34 43.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.533 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.79 -31.32 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.042 1.828 . . . . 0.0 112.986 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.72 -38.56 70.49 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 30' ' ' SER . 79.0 m -105.58 119.44 39.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.76 94.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.068 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -106.62 146.36 30.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.625 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -74.01 162.91 28.54 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.589 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -125.55 137.73 53.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.9 mt -117.67 128.69 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.4 tt -129.98 138.0 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.207 0.527 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.9 m -114.74 148.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.83 121.96 46.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 47' ' ' ARG . 87.0 mt -87.57 152.45 22.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -59.78 -24.93 64.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.878 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -80.43 7.58 9.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.139 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.01 63.24 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.648 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB2' HD12 ' A' ' 43' ' ' LEU . 57.5 mmm-85 -101.76 147.45 26.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.1 mt-10 -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.864 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 87.9 mt -120.96 145.43 47.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.676 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -105.07 128.67 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.116 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.22 142.1 47.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.1 t0 -92.9 116.3 66.28 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 28.8 Cg_endo -61.61 -18.89 62.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.071 2.514 . . . . 0.0 113.835 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -68.1 -21.66 64.94 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 0.0 111.565 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 58' ' ' VAL . 76.6 mm-40 -84.66 132.43 34.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.15 -40.24 95.32 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.086 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' VAL . 68.5 p-90 -63.19 -30.69 71.79 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 55' ' ' GLU . 53.4 t -63.46 -43.69 98.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.413 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.97 -42.11 97.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -62.76 -41.13 99.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.314 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 57' ' ' TRP . 64.4 t -63.17 -46.63 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.36 -47.51 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.211 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -40.97 91.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.613 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -62.3 -49.08 77.05 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.869 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 48.8 m-85 -71.57 -37.12 71.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.476 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.244 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.113 0.483 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.34 70.54 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.069 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 57.6 mtpt -96.42 4.84 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -93.3 9.83 34.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.83 138.77 48.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.95 135.48 47.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.28 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -97.84 81.11 2.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -64.62 -40.1 94.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.685 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.6 m -92.97 87.32 5.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.4 mt -63.25 -44.96 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 110.227 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 10' ' ' ILE . 68.8 mttm -127.66 147.75 50.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.943 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -128.15 158.84 36.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.8 158.35 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.3 p -91.06 -3.43 57.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -127.51 73.25 77.98 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.681 0.277 . . . . 0.0 111.6 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 161.79 34.3 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.973 2.449 . . . . 0.0 113.319 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.23 130.04 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.488 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 61' ' ' VAL . 66.5 m80 -112.88 98.05 43.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.08 155.25 33.47 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 112.615 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -80.07 3.66 19.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.502 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -96.62 17.54 16.17 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.58 121.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.04 -47.49 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.913 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.07 147.42 52.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt -119.53 112.51 19.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.893 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -110.19 147.55 33.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.0 111.375 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -126.96 150.67 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.607 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.3 mt -119.86 124.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.612 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.75 138.99 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p -72.16 -55.12 7.8 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.814 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.16 -154.22 20.13 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.113 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.5 -25.69 3.63 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.233 1.955 . . . . 0.0 112.772 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' A' ' 3' ' ' LYS . 84.6 m-70 -71.08 -40.19 71.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 74.6 m -113.46 131.7 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.34 92.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -131.14 149.29 52.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 111.782 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 59.2 m -64.05 138.57 58.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.984 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -116.94 139.76 50.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 0.0 111.677 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -118.34 129.97 73.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 48' ' ' GLU . 17.7 tt -131.66 135.9 58.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.55 HG12 ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -112.98 149.12 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.86 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.89 123.2 49.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.94 154.79 20.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.3 p -60.04 -19.64 53.88 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.567 0.542 . . . . 0.0 112.131 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.52 5.27 36.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.008 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.49 23.15 57.16 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -99.75 148.08 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.649 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.3 mt-10 -118.83 131.8 56.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 88.9 mt -120.67 143.89 48.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.669 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 t -98.75 128.45 44.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.094 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -115.61 143.31 45.54 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.408 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -95.87 113.97 63.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG3' ' O ' ' A' ' 37' ' ' THR . 54.4 Cg_endo -67.78 -15.87 45.0 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 113.638 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.74 -37.66 85.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.398 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -74.17 126.22 30.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.692 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -62.78 -41.37 99.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.52 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -63.19 -30.47 71.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.366 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.1 -44.5 99.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.067 0.46 . . . . 0.0 109.768 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -62.11 -39.24 91.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -60.9 -42.28 97.73 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG11 ' CG ' ' A' ' 18' ' ' HIS . 74.6 t -66.83 -44.57 88.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.88 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.93 -48.17 89.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.392 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.16 -41.13 95.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -63.65 -43.66 96.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.937 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.33 -47.02 87.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.062 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.105 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.948 0.404 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.29 91.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.62 -11.3 60.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.689 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.72 1.74 57.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.158 0.504 . . . . 0.0 110.257 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 30' ' ' SER . 68.4 tp -87.67 122.7 31.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.827 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -149.67 163.1 38.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -92.57 96.31 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.75 -39.97 94.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.113 0.482 . . . . 0.0 111.534 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.9 m -93.21 92.47 7.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.411 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.3 mt -63.69 -45.02 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.219 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' A' ' 10' ' ' ILE . 58.6 mtmt -128.18 148.52 50.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -128.46 158.92 37.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.033 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 47.1 t80 -108.15 142.4 38.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.992 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 80.7 p -62.18 -36.34 81.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.05 71.64 81.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 O-C-N 122.175 -0.328 . . . . 0.0 111.776 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.94 156.23 52.54 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.446 2.097 . . . . 0.0 112.55 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -87.79 119.92 28.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.459 ' NE2' HD13 ' A' ' 22' ' ' ILE . 22.2 t-160 -116.24 100.72 53.7 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.15 139.64 79.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.005 2.47 . . . . 0.0 112.448 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.13 0.56 40.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.452 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.58 17.83 20.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.522 HG22 HD22 ' A' ' 43' ' ' LEU . 39.6 pt -66.83 147.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.57 -29.81 12.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.458 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -139.39 148.49 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.224 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.8 tt -128.99 106.85 9.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.642 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HB3' HG23 ' A' ' 40' ' ' ILE . 32.4 tpt180 -100.24 128.05 46.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.236 0.541 . . . . 0.0 111.477 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.68 125.72 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.53 124.59 71.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.116 0.484 . . . . 0.0 111.635 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.14 154.86 30.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 37' ' ' THR . 77.6 p -70.43 -42.91 70.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.794 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.98 -162.12 31.94 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.38 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -16.18 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.727 2.285 . . . . 0.0 114.222 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -104.79 -2.07 25.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 41.3 t -127.73 132.75 49.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.81 93.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.85 156.47 45.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 30' ' ' SER . 74.5 p -74.33 161.9 29.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.547 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -149.69 149.55 30.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.702 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.76 129.05 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.662 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.2 tt -128.49 137.25 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 0.0 110.645 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.765 HG12 ' HG ' ' A' ' 25' ' ' LEU . 26.8 m -115.42 152.68 17.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -118.74 123.53 45.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 22' ' ' ILE . 2.3 mm? -87.41 157.95 19.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.142 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.6 p -59.95 -21.19 60.87 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.655 0.597 . . . . 0.0 112.453 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.0 6.7 34.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.92 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.61 58.96 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.082 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -99.0 128.33 45.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.662 ' HB3' HD11 ' A' ' 40' ' ' ILE . 99.9 mt-10 -104.74 130.64 52.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 111.043 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -119.4 144.48 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.097 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.75 127.9 47.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.3 mt -112.51 145.52 40.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.76 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.23 114.59 59.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.09 -17.96 40.37 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.966 2.444 . . . . 0.0 113.438 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -70.19 -21.43 63.04 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 14' ' ' SER . 81.1 mm-40 -85.7 126.37 33.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.88 -40.52 97.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.652 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -63.33 -34.11 76.99 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.295 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.86 -44.41 96.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.144 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -62.23 -39.87 94.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.069 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -61.2 -41.63 97.17 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.45 -44.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.23 -47.43 93.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.16 -39.78 94.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.64 -44.98 95.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.853 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.27 -39.21 86.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.176 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.653 0.263 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.32 43.78 13.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.4 1.62 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.19 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 60.04 39.44 19.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.206 0.527 . . . . 0.0 110.893 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 68.8 tp -109.66 123.68 49.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.264 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -128.98 147.25 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.578 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.5 m -87.74 89.9 8.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -67.81 -23.19 65.16 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.9 m -97.89 85.01 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.739 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.56 -45.39 85.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.498 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -130.24 145.05 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.216 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.6 p -130.58 158.99 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -92.47 140.61 29.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.3 m -61.01 -39.6 90.35 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.04 76.12 76.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.565 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.83 158.93 51.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.73 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.18 140.23 33.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.423 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -111.6 99.98 46.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.09 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.04 145.92 96.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.079 2.519 . . . . 0.0 112.644 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -80.01 3.17 20.99 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.202 0.525 . . . . 0.0 110.821 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.18 20.88 12.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.195 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 65' ' ' PHE . 83.9 mt -75.72 120.41 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.778 0.323 . . . . 0.0 110.152 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -89.02 -47.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -133.86 149.18 51.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -120.55 115.21 22.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HB2' HG23 ' A' ' 40' ' ' ILE . 41.1 mmt180 -104.97 142.8 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.203 0.525 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.75 128.44 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.93 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.6 mt -108.42 123.88 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.41 146.49 46.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.8 p -70.79 -42.81 69.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.08 -162.73 26.93 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.735 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.35 -24.91 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.038 1.825 . . . . 0.0 112.385 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 95.1 m-70 -71.75 -39.41 70.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 30' ' ' SER . 83.3 m -113.9 131.15 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.73 0.3 . . . . 0.0 111.618 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.0 95.91 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.816 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -118.56 159.04 24.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.316 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.6 p -79.45 164.5 23.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.08 139.62 51.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 111.245 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.68 127.56 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.6 tt -129.66 138.22 54.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.289 0.566 . . . . 0.0 111.119 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.51 HG12 ' HG ' ' A' ' 25' ' ' LEU . 29.3 m -115.05 147.33 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.491 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -109.45 117.51 34.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' ARG . 87.8 mt -86.34 153.7 21.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.281 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m -57.04 -34.24 68.03 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.821 0.7 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.57 6.78 3.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.615 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.69 22.98 60.87 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.666 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HB3' HD12 ' A' ' 43' ' ' LEU . 41.4 ttm180 -101.11 142.19 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.061 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -116.34 131.65 56.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.881 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.7 mt -121.36 146.05 47.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.1 t -102.92 126.3 50.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -109.57 145.35 36.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.731 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -90.11 114.46 60.98 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.06 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.81 -16.76 41.92 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.048 2.499 . . . . 0.0 113.318 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -62.12 -37.23 84.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.24 121.76 23.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.772 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -63.93 -31.66 72.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.315 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.09 -43.85 99.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.41 -38.85 91.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.97 -42.09 97.65 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.43 -44.37 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.94 -47.25 94.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 98.7 mt-10 -64.58 -41.45 96.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.836 0.351 . . . . 0.0 110.539 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.01 -43.93 94.16 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 22' ' ' ILE . 77.7 t80 -61.33 -46.89 88.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 29.3 mt . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.955 0.407 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.62 153.44 39.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.8 17.27 21.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.74 -37.76 87.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.82 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.52 121.77 22.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.109 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.62 148.58 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.613 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.31 97.92 10.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.48 -39.57 94.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.413 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.92 98.9 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.16 -43.46 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.319 0.58 . . . . 0.0 109.888 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -124.29 152.77 42.65 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 70.1 p -126.36 158.5 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 11.6 t80 -81.3 118.39 22.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.781 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -98.66 -15.18 19.51 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 60.3 mtpt -72.38 131.01 85.25 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.496 0.188 . . . . 0.0 110.951 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.77 71.7 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.255 2.636 . . . . 0.0 113.863 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -118.8 127.11 53.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.625 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -111.26 99.15 42.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.82 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.72 129.37 10.78 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.176 1.917 . . . . 0.0 112.752 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -81.09 3.25 23.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.565 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.8 15.42 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -77.87 95.64 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -71.67 -42.77 67.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.51 149.6 49.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.149 0.499 . . . . 0.0 111.53 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD13 HG12 ' A' ' 41' ' ' VAL . 58.5 tp -119.29 120.92 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.03 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 40' ' ' ILE . 85.0 mtp180 -109.9 139.58 44.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -116.83 126.68 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.787 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.08 122.42 21.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 9.4 p -72.51 -43.47 63.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.581 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.37 48.36 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.139 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.27 -25.63 26.03 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.318 2.012 . . . . 0.0 112.83 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.07 -40.3 87.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 30' ' ' SER . 92.0 m -117.3 119.77 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.714 0.292 . . . . 0.0 110.609 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.69 95.3 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -98.31 131.03 44.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.3 m -63.66 139.01 58.73 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.118 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.05 127.9 51.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.094 0.473 . . . . 0.0 112.227 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.35 129.09 75.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -131.34 138.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.253 0.549 . . . . 0.0 110.995 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 25' ' ' LEU . 31.2 m -112.81 149.76 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -116.31 120.02 37.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.27 153.62 23.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.665 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.5 p -59.7 -21.1 60.15 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.49 0.494 . . . . 0.0 112.122 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.52 7.27 17.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 110.91 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.2 20.62 66.82 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -101.78 127.55 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.647 0.26 . . . . 0.0 110.899 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -104.45 129.61 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.363 . . . . 0.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.66 140.68 49.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.22 131.86 44.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD22 ' CH2' ' A' ' 57' ' ' TRP . 82.0 mt -117.0 145.93 43.36 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.196 0.522 . . . . 0.0 111.691 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 45.1 t0 -97.1 117.12 66.05 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.35 -18.58 53.76 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 123.222 2.615 . . . . 0.0 113.913 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.26 -24.23 66.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 58' ' ' VAL . 77.1 mm-40 -81.87 135.12 35.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.062 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.04 -42.07 98.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.421 ' CH2' HD22 ' A' ' 51' ' ' LEU . 61.4 p-90 -62.87 -29.65 70.92 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 55' ' ' GLU . 57.8 t -64.45 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.71 -38.5 85.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.59 -39.37 90.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.199 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.6 t -61.0 -47.83 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.351 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG23 HD21 ' A' ' 25' ' ' LEU . 15.0 p -72.4 -41.96 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.02 -42.87 79.97 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.28 -41.6 73.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 32.0 m-85 -71.37 -37.19 71.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.023 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.77 92.69 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.861 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.26 4.96 52.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.336 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 59.56 39.06 21.98 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.214 0.53 . . . . 0.0 110.937 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.484 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 69.1 tp -109.92 124.93 52.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.527 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -125.45 134.5 52.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.476 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 m -78.57 92.52 4.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.168 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.8 m -90.28 95.91 10.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.912 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -83.79 -27.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.569 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -130.07 143.66 50.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.431 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 52' ' ' ASP . 72.1 p -131.41 159.57 37.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 111.746 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.85 128.75 55.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -64.25 -37.27 86.88 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -128.36 72.77 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.65 159.56 48.46 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.493 2.129 . . . . 0.0 111.85 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 20.5 p90 -76.27 168.26 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -109.62 98.34 32.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.403 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 17' ' ' PHE . 3.2 Cg_exo -81.91 124.11 4.34 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.959 2.439 . . . . 0.0 112.479 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.14 -1.05 51.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.45 20.78 13.17 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.94 120.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.148 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -101.85 -35.8 8.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.532 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -132.14 144.35 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.728 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -127.02 110.79 13.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.24 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 40' ' ' ILE . 82.6 mtt85 -101.5 137.47 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.0 111.456 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -117.46 129.08 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.064 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.85 124.02 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.16 147.71 48.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 p -71.66 -53.01 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.5 -159.98 29.22 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.738 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.06 -24.13 4.11 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.043 1.829 . . . . 0.0 112.288 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 99.8 m-70 -73.06 -39.96 65.46 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.85 131.84 55.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.754 0.311 . . . . 0.0 111.053 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.66 93.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.139 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -129.35 158.1 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.849 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.4 p -71.5 158.11 36.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.654 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -129.69 139.61 51.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.929 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 62' ' ' VAL . 87.3 mt -120.8 129.63 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.118 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.9 tt -128.73 135.64 61.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.05 0.452 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.1 m -112.78 148.08 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.0 110.765 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.37 124.14 49.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.855 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.01 159.3 17.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.731 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.3 p -59.56 -21.21 59.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.415 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.34 5.2 35.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.075 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 25.85 54.53 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.026 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -101.07 142.45 32.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.678 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -116.04 131.38 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 110.823 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -120.44 145.19 47.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.55 126.34 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 58' ' ' VAL . 84.7 mt -116.91 145.23 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' HB ' ' A' ' 12' ' ' THR . 45.4 t0 -108.59 113.74 59.64 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.72 -12.93 33.88 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.652 2.901 . . . . 0.0 115.514 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.04 -21.43 66.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.142 0.428 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -95.86 135.61 37.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.718 0.294 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 26.9 m120 -62.3 -39.03 91.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.503 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.44 -45.03 92.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.159 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 51' ' ' LEU . 63.4 t -62.52 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -61.41 -38.22 86.33 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.556 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 56' ' ' ASN . 27.4 mmm180 -59.96 -41.05 91.08 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.438 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 75.5 t -64.09 -46.51 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 77.8 t -63.72 -47.26 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.656 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.24 -38.94 92.86 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.417 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 47.6 m-85 -70.81 -36.53 73.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.71 0.29 . . . . 0.0 111.749 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 25' ' ' LEU . 88.3 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.312 -0.852 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.44 154.35 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 12.84 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 110.754 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -125.64 146.65 49.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -85.09 87.85 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.45 140.87 51.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 99.7 m -99.06 159.15 15.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.241 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -61.86 -39.89 93.47 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.308 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.3 m -88.77 127.16 35.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.8 pt -104.01 -9.55 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -147.93 137.57 22.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.142 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.8 p -129.64 160.24 33.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 9.2 t80 -101.93 117.57 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -93.44 -12.44 29.77 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 35.4 mmtp -84.61 122.78 74.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.77 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HA ' ' CD2' ' A' ' 57' ' ' TRP . 74.4 Cg_exo -54.67 129.39 34.75 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.455 2.104 . . . . 0.0 112.794 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -160.93 137.17 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -119.4 90.64 42.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.78 124.38 11.83 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.556 2.171 . . . . 0.0 112.178 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -83.72 0.54 46.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.788 0.328 . . . . 0.0 111.452 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.83 14.22 29.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -75.22 119.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.938 0.399 . . . . 0.0 110.073 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -102.51 -42.96 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -130.41 149.69 51.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 111.478 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD13 HG12 ' A' ' 41' ' ' VAL . 65.9 tp -118.52 122.03 41.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.375 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' A' ' 40' ' ' ILE . 99.7 mtt180 -109.48 143.73 38.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.807 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.7 128.97 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.376 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 81.5 mt -104.43 123.24 58.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.45 139.36 47.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.9 p -71.19 -42.14 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.83 -170.51 36.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.591 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.43 -22.64 15.94 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.065 1.844 . . . . 0.0 112.316 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -71.14 -39.8 71.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' SER . 71.3 m -116.67 131.23 57.0 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.39 95.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.217 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -111.33 158.27 19.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.003 0.43 . . . . 0.0 111.783 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.8 p -83.11 166.38 18.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.465 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.5 mt-10 -125.24 143.44 50.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 110.986 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -117.49 127.92 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.997 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.5 tt -127.32 137.66 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.168 0.508 . . . . 0.0 110.537 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 25' ' ' LEU . 27.3 m -112.73 148.4 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.973 0.416 . . . . 0.0 110.745 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.66 123.14 48.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.75 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.99 153.92 20.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.5 p -60.07 -19.5 53.39 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.597 0.561 . . . . 0.0 112.17 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 3.98 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.93 56.72 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.233 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -101.46 139.19 37.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.872 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -117.44 129.29 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.672 0.272 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.421 ' O ' HG13 ' A' ' 40' ' ' ILE . 87.7 mt -120.51 135.9 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.629 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.86 123.95 46.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -117.29 148.04 42.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -87.72 118.4 69.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.134 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.56 -19.34 64.36 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.171 2.581 . . . . 0.0 113.853 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.18 -21.24 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.83 133.59 35.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.007 0.432 . . . . 0.0 111.02 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.35 -40.51 96.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . 0.49 ' CD2' ' HA ' ' A' ' 16' ' ' PRO . 56.7 p-90 -64.0 -30.35 71.43 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.644 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.17 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.043 0.449 . . . . 0.0 109.927 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.96 -40.0 91.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.317 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -63.05 -38.34 90.8 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.553 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.582 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 66.4 t -59.81 -47.57 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.377 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.06 -38.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.54 -44.63 77.87 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.65 -41.6 96.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 41.0 m-85 -70.9 -34.88 72.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 111.577 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.679 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.946 0.403 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.96 150.84 35.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.783 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -90.97 1.3 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -90.02 2.83 54.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.069 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 33' ' ' HIS . 60.8 tp -79.06 119.29 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.685 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -146.51 147.54 31.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.238 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 8.5 m -76.31 93.6 3.47 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.72 0.295 . . . . 0.0 110.353 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -63.37 -41.14 98.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.082 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.7 m -93.28 93.13 8.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.72 -44.34 98.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -116.43 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -130.12 158.46 39.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.413 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t80 -108.48 138.74 44.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 71.0 m -61.71 -41.45 97.62 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -131.8 72.84 79.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.2 Cg_endo -72.07 156.23 56.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.752 2.302 . . . . 0.0 113.358 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.47 131.01 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.843 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -100.83 107.43 49.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.656 0.265 . . . . 0.0 110.79 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.58 153.51 34.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.932 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.28 3.25 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.402 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -98.12 20.2 12.79 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.83 118.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -91.75 -45.74 8.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.72 149.07 52.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.779 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.6 tt -124.88 114.7 19.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.457 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -107.33 136.39 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.206 0.527 . . . . 0.0 111.482 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -117.35 127.74 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.954 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -108.49 121.39 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 110.719 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.22 144.28 50.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.83 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.424 ' O ' HD21 ' A' ' 5' ' ' LEU . 2.8 p -72.17 -54.48 9.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.68 -165.09 25.1 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.113 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.93 -29.14 8.68 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.676 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.6 ' HB2' HD23 ' A' ' 5' ' ' LEU . 92.3 m-70 -71.48 -38.38 71.24 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 t -113.53 128.46 56.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.742 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.58 93.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -127.31 139.97 52.52 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -64.72 137.64 57.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.595 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.2 mt-10 -125.56 140.9 52.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 130.73 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 48' ' ' GLU . 20.5 tt -128.58 141.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.4 m -114.57 149.46 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 111.042 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -110.6 122.34 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.178 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 47' ' ' ARG . 82.0 mt -90.27 153.17 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.7 p -60.57 -19.88 58.82 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.69 0.619 . . . . 0.0 112.124 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -85.13 4.22 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.94 58.93 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.324 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB2' HD12 ' A' ' 43' ' ' LEU . 96.5 mtt-85 -101.26 158.81 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.545 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.3 mt-10 -128.1 133.33 49.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.4 mt -123.9 142.54 51.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.215 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.8 m -100.12 133.14 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.71 148.34 39.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -98.64 110.41 56.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.49 -14.3 36.73 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.086 2.524 . . . . 0.0 113.54 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -61.68 -37.08 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 14' ' ' SER . 77.5 mm-40 -77.29 127.88 33.37 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.84 -40.34 97.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -64.52 -32.8 74.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.87 -43.23 97.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -61.22 -41.41 96.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.51 -46.0 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.601 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.65 -49.2 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.77 -43.06 89.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.0 -40.04 83.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.978 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -62.37 -48.59 79.08 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.943 -179.521 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.979 0.418 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.32 156.61 42.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.95 17.06 24.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.427 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -110.34 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.14 77.51 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -146.5 138.97 25.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.5 m -86.19 145.57 26.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -62.27 -40.86 97.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.066 0.46 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.2 m -105.99 105.46 15.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.1 mt -63.24 -47.2 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.845 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.631 ' HG3' HG22 ' A' ' 10' ' ' ILE . 64.4 mttp -132.21 149.01 52.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 111.303 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 p -129.8 156.92 43.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.128 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 35.9 t80 -108.7 142.46 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.6 p -62.04 -35.64 79.21 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.58 73.53 80.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.505 0.193 . . . . 0.0 110.964 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.31 156.74 54.57 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.652 2.235 . . . . 0.0 113.159 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -86.88 143.54 27.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.105 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.535 ' CG ' HG11 ' A' ' 61' ' ' VAL . 66.5 m80 -119.06 90.95 42.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.22 147.74 94.47 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.195 2.597 . . . . 0.0 112.582 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -81.06 3.27 23.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -96.52 16.37 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.892 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.1 mt -76.06 118.38 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.74 -44.34 8.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -130.62 149.18 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.4 tt -124.42 115.91 21.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -108.31 132.23 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.32 0.581 . . . . 0.0 112.046 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.8 t -122.49 128.47 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.381 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.1 148.63 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.105 0.479 . . . . 0.0 111.776 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.95 148.95 36.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.084 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 79.5 p -70.59 -40.56 73.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.713 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.88 -156.62 36.27 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.922 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.87 -20.09 7.91 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.167 1.911 . . . . 0.0 112.217 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -70.76 -40.18 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.498 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' SER . 97.6 m -124.48 149.08 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.67 -4.58 55.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.05 139.9 41.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 111.6 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.6 m -64.62 137.41 57.82 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.083 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.99 132.89 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 111.753 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -117.53 130.28 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -132.15 144.18 37.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 110.896 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.7 m -115.16 149.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.759 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -114.37 119.54 37.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.423 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.63 153.18 20.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.0 p -60.53 -20.13 59.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.063 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.52 4.09 37.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.839 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.11 22.46 57.25 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.22 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -100.89 144.15 30.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.318 . . . . 0.0 111.118 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.6 mt-10 -121.29 130.28 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.4 141.7 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 87.5 m -97.06 134.64 40.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.392 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.28 144.15 44.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.778 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -96.55 116.51 66.16 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.06 -13.25 39.17 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.291 2.66 . . . . 0.0 113.946 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.52 -38.43 87.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -79.63 127.66 32.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.751 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -69.19 -35.62 76.45 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -65.21 -31.81 73.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.635 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.6 -42.11 94.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -61.78 -38.24 87.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.59 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -60.48 -41.31 93.97 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.888 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.535 HG11 ' CG ' ' A' ' 18' ' ' HIS . 78.8 t -65.1 -44.33 95.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.292 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -61.47 -47.13 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.843 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.45 -39.58 94.1 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.357 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.24 -46.03 92.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.284 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -68.1 -38.15 81.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.436 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.171 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HA ' ' OE2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER . . . . . 0 C--O 1.233 0.218 0 CA-C-O 120.877 0.37 . . . . 0.0 110.451 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.58 -41.13 98.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.586 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.4 m -93.58 87.95 5.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.27 -43.94 98.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.255 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -121.42 149.09 43.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.27 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -127.28 158.63 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.77 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -89.82 117.96 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.2 p -94.94 -19.71 20.01 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.02 129.73 82.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 110.579 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.26 129.05 33.14 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.46 2.107 . . . . 0.0 112.916 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -160.06 125.17 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.506 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -122.51 89.31 49.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.284 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.91 134.55 13.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.223 1.949 . . . . 0.0 112.577 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.72 3.14 23.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.725 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -94.06 8.5 41.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -82.16 119.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.264 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -108.17 -34.95 6.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.031 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -140.0 159.55 41.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.244 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 144.29 29.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 110.296 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -119.74 145.01 46.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.07 126.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.535 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.19 124.82 66.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 110.709 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.32 129.53 39.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.92 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 3.6 p -72.98 -53.17 11.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.152 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.15 -165.65 42.35 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.19 -34.98 87.82 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.039 2.493 . . . . 0.0 113.259 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -64.78 -40.53 95.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 30' ' ' SER . 94.8 m -118.1 124.68 48.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.278 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.07 96.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.37 142.34 36.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.3 m -67.81 138.28 56.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.865 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' HA ' ' A' ' 7' ' ' CYS . 46.5 mt-10 -104.48 125.47 50.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.42 128.66 75.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 48' ' ' GLU . 21.2 tt -132.38 141.58 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.077 0.465 . . . . 0.0 110.867 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.17 151.54 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.777 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -113.56 122.59 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.665 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -91.4 153.54 19.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -21.93 62.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.304 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.49 10.47 12.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 25.88 64.3 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -101.62 145.72 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -117.83 135.08 54.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.745 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.0 tp -128.41 128.19 43.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.83 129.82 37.72 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.945 0.403 . . . . 0.0 110.397 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.3 mt -116.37 145.84 42.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.953 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -92.22 118.75 68.28 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.164 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.67 -20.63 69.66 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.119 2.546 . . . . 0.0 113.936 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -68.91 -20.99 64.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.592 0.234 . . . . 0.0 111.608 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.28 132.55 35.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 111.083 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.91 -42.76 99.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.182 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -62.36 -29.96 70.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.8 -42.71 96.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 109.895 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -61.72 -38.68 88.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.725 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -61.47 -40.14 93.46 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.288 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.482 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.8 t -61.27 -48.65 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.335 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.67 -48.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.694 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.92 -46.94 79.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.72 -41.69 91.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 33.0 m-85 -71.31 -36.3 71.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.663 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.051 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.6 m . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.48 -41.06 96.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.573 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.2 m -97.56 127.21 43.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.61 -27.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 111.133 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -133.79 143.21 48.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -132.13 158.8 40.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.896 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -108.86 143.51 37.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.388 . . . . 0.0 110.946 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.4 p -90.6 -11.01 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.652 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -78.95 124.46 84.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.91 133.66 59.38 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.874 2.382 . . . . 0.0 113.191 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -154.6 111.62 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -136.33 89.03 19.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.792 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.65 142.36 94.1 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.759 2.306 . . . . 0.0 112.379 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -81.67 2.55 29.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.037 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.61 14.7 27.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.74 119.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -89.53 -48.73 7.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.78 150.48 49.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.155 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.3 tt -119.18 116.6 26.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.184 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -106.68 144.62 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.406 0.622 . . . . 0.0 112.011 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.9 t -115.58 128.79 72.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.613 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.9 mt -106.29 127.0 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.874 0.368 . . . . 0.0 111.08 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.12 142.26 57.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 78.5 p -70.74 -41.49 71.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.0 -174.34 43.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.533 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.79 -31.32 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.042 1.828 . . . . 0.0 112.986 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.72 -38.56 70.49 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 30' ' ' SER . 79.0 m -105.58 119.44 39.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.76 94.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.068 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -106.62 146.36 30.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.625 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -74.01 162.91 28.54 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.589 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -125.55 137.73 53.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.9 mt -117.67 128.69 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.4 tt -129.98 138.0 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.207 0.527 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.9 m -114.74 148.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.83 121.96 46.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 47' ' ' ARG . 87.0 mt -87.57 152.45 22.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -59.78 -24.93 64.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.878 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -80.43 7.58 9.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.139 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.01 63.24 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.648 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB2' HD12 ' A' ' 43' ' ' LEU . 57.5 mmm-85 -101.76 147.45 26.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.1 mt-10 -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.864 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 87.9 mt -120.96 145.43 47.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.676 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -105.07 128.67 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.116 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.22 142.1 47.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.1 t0 -92.9 116.3 66.28 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 28.8 Cg_endo -61.61 -18.89 62.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.071 2.514 . . . . 0.0 113.835 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -68.1 -21.66 64.94 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 0.0 111.565 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 58' ' ' VAL . 76.6 mm-40 -84.66 132.43 34.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.15 -40.24 95.32 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.086 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' VAL . 68.5 p-90 -63.19 -30.69 71.79 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 55' ' ' GLU . 53.4 t -63.46 -43.69 98.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.413 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.97 -42.11 97.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -62.76 -41.13 99.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.314 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 57' ' ' TRP . 64.4 t -63.17 -46.63 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.36 -47.51 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.211 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -40.97 91.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.613 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -62.3 -49.08 77.05 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.869 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 48.8 m-85 -71.57 -37.12 71.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.476 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.244 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.231 0.125 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -64.62 -40.1 94.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.685 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.6 m -92.97 87.32 5.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.44 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.4 mt -63.25 -44.96 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 110.227 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 10' ' ' ILE . 68.8 mttm -127.66 147.75 50.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.943 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -128.15 158.84 36.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.8 158.35 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.3 p -91.06 -3.43 57.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -127.51 73.25 77.98 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.681 0.277 . . . . 0.0 111.6 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 161.79 34.3 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.973 2.449 . . . . 0.0 113.319 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.23 130.04 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.488 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 61' ' ' VAL . 94.8 m-70 -112.88 98.05 43.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.08 155.25 33.47 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 112.615 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -80.07 3.66 19.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.502 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -96.62 17.54 16.17 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.58 121.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.04 -47.49 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.913 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.07 147.42 52.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.55 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt -119.53 112.51 19.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.893 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -110.19 147.55 33.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.0 111.375 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -126.96 150.67 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.607 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.3 mt -119.86 124.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.612 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.75 138.99 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p -72.16 -55.12 7.8 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.814 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.16 -154.22 20.13 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.113 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.5 -25.69 3.63 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.233 1.955 . . . . 0.0 112.772 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 m-70 -71.08 -40.19 71.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 74.6 m -113.46 131.7 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.34 92.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -131.14 149.29 52.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 111.782 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 59.2 m -64.05 138.57 58.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.984 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -116.94 139.76 50.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 0.0 111.677 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -118.34 129.97 73.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 48' ' ' GLU . 17.7 tt -131.66 135.9 58.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.55 HG12 ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -112.98 149.12 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.86 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.89 123.2 49.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.94 154.79 20.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.3 p -60.04 -19.64 53.88 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.567 0.542 . . . . 0.0 112.131 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.52 5.27 36.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.008 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.49 23.15 57.16 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -99.75 148.08 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.649 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.3 mt-10 -118.83 131.8 56.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 88.9 mt -120.67 143.89 48.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.669 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 t -98.75 128.45 44.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.094 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -115.61 143.31 45.54 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.408 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -95.87 113.97 63.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG3' ' O ' ' A' ' 37' ' ' THR . 54.4 Cg_endo -67.78 -15.87 45.0 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 113.638 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.74 -37.66 85.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.398 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -74.17 126.22 30.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.692 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -62.78 -41.37 99.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.52 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -63.19 -30.47 71.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.366 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.1 -44.5 99.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.067 0.46 . . . . 0.0 109.768 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -62.11 -39.24 91.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -60.9 -42.28 97.73 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.402 HG11 ' CG ' ' A' ' 18' ' ' HIS . 74.6 t -66.83 -44.57 88.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.88 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.93 -48.17 89.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.392 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.16 -41.13 95.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -63.65 -43.66 96.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.937 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.33 -47.02 87.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.062 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.105 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.231 0.121 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.75 -39.97 94.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.113 0.482 . . . . 0.0 111.534 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.9 m -93.21 92.47 7.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.411 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.3 mt -63.69 -45.02 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.219 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' A' ' 10' ' ' ILE . 58.6 mtmt -128.18 148.52 50.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -128.46 158.92 37.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.033 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 47.1 t80 -108.15 142.4 38.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.992 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 80.7 p -62.18 -36.34 81.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.05 71.64 81.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 O-C-N 122.175 -0.328 . . . . 0.0 111.776 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.94 156.23 52.54 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.446 2.097 . . . . 0.0 112.55 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -87.79 119.92 28.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.459 ' NE2' HD13 ' A' ' 22' ' ' ILE . 22.2 t-160 -116.24 100.72 53.7 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.15 139.64 79.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.005 2.47 . . . . 0.0 112.448 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.13 0.56 40.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.452 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.58 17.83 20.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.522 HG22 HD22 ' A' ' 43' ' ' LEU . 39.6 pt -66.83 147.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.57 -29.81 12.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.458 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -139.39 148.49 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.224 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.8 tt -128.99 106.85 9.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.642 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HB3' HG23 ' A' ' 40' ' ' ILE . 32.4 tpt180 -100.24 128.05 46.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.236 0.541 . . . . 0.0 111.477 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.68 125.72 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.53 124.59 71.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.116 0.484 . . . . 0.0 111.635 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.14 154.86 30.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 37' ' ' THR . 77.6 p -70.43 -42.91 70.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.794 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.98 -162.12 31.94 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.38 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -16.18 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.727 2.285 . . . . 0.0 114.222 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -104.79 -2.07 25.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 41.3 t -127.73 132.75 49.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.81 93.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.85 156.47 45.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 30' ' ' SER . 74.5 p -74.33 161.9 29.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.547 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -149.69 149.55 30.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.702 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.76 129.05 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.662 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.2 tt -128.49 137.25 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 0.0 110.645 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.765 HG12 ' HG ' ' A' ' 25' ' ' LEU . 26.8 m -115.42 152.68 17.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -118.74 123.53 45.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 22' ' ' ILE . 2.3 mm? -87.41 157.95 19.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.142 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.6 p -59.95 -21.19 60.87 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.655 0.597 . . . . 0.0 112.453 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.0 6.7 34.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.92 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.61 58.96 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.082 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -99.0 128.33 45.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.662 ' HB3' HD11 ' A' ' 40' ' ' ILE . 99.9 mt-10 -104.74 130.64 52.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 111.043 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -119.4 144.48 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.097 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.75 127.9 47.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.3 mt -112.51 145.52 40.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.76 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.23 114.59 59.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.09 -17.96 40.37 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.966 2.444 . . . . 0.0 113.438 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -70.19 -21.43 63.04 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 14' ' ' SER . 81.1 mm-40 -85.7 126.37 33.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.88 -40.52 97.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.652 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -63.33 -34.11 76.99 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.295 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.86 -44.41 96.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.144 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -62.23 -39.87 94.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.069 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -61.2 -41.63 97.17 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.45 -44.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.23 -47.43 93.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.16 -39.78 94.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.64 -44.98 95.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.853 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.27 -39.21 86.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.176 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -67.81 -23.19 65.16 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.9 m -97.89 85.01 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.739 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.56 -45.39 85.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.498 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -130.24 145.05 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.216 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.6 p -130.58 158.99 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -92.47 140.61 29.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.3 m -61.01 -39.6 90.35 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.04 76.12 76.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.565 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.83 158.93 51.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.73 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.18 140.23 33.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.423 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -111.6 99.98 46.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.09 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.04 145.92 96.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.079 2.519 . . . . 0.0 112.644 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -80.01 3.17 20.99 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.202 0.525 . . . . 0.0 110.821 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.18 20.88 12.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.195 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 65' ' ' PHE . 83.9 mt -75.72 120.41 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.778 0.323 . . . . 0.0 110.152 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -89.02 -47.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -133.86 149.18 51.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -120.55 115.21 22.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HB2' HG23 ' A' ' 40' ' ' ILE . 41.1 mmt180 -104.97 142.8 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.203 0.525 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.75 128.44 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.93 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.6 mt -108.42 123.88 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.41 146.49 46.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.8 p -70.79 -42.81 69.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.08 -162.73 26.93 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.735 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.35 -24.91 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.038 1.825 . . . . 0.0 112.385 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -71.75 -39.41 70.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 30' ' ' SER . 83.3 m -113.9 131.15 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.73 0.3 . . . . 0.0 111.618 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.0 95.91 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.816 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -118.56 159.04 24.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.316 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.6 p -79.45 164.5 23.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.08 139.62 51.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 111.245 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.68 127.56 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.6 tt -129.66 138.22 54.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.289 0.566 . . . . 0.0 111.119 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.51 HG12 ' HG ' ' A' ' 25' ' ' LEU . 29.3 m -115.05 147.33 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.491 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -109.45 117.51 34.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' ARG . 87.8 mt -86.34 153.7 21.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.281 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m -57.04 -34.24 68.03 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.821 0.7 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.57 6.78 3.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.615 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.69 22.98 60.87 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.666 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HB3' HD12 ' A' ' 43' ' ' LEU . 41.4 ttm180 -101.11 142.19 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.061 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -116.34 131.65 56.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.881 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.7 mt -121.36 146.05 47.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.1 t -102.92 126.3 50.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -109.57 145.35 36.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.731 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -90.11 114.46 60.98 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.06 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.81 -16.76 41.92 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.048 2.499 . . . . 0.0 113.318 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -62.12 -37.23 84.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.24 121.76 23.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.772 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -63.93 -31.66 72.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.315 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.09 -43.85 99.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.41 -38.85 91.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.97 -42.09 97.65 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.43 -44.37 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.94 -47.25 94.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 98.7 mt-10 -64.58 -41.45 96.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.836 0.351 . . . . 0.0 110.539 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.01 -43.93 94.16 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 22' ' ' ILE . 77.7 t80 -61.33 -46.89 88.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 29.3 mt . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.48 -39.57 94.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.413 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.92 98.9 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.16 -43.46 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.319 0.58 . . . . 0.0 109.888 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -124.29 152.77 42.65 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 70.1 p -126.36 158.5 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 11.6 t80 -81.3 118.39 22.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.781 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -98.66 -15.18 19.51 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 60.3 mtpt -72.38 131.01 85.25 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.496 0.188 . . . . 0.0 110.951 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.77 71.7 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.255 2.636 . . . . 0.0 113.863 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -118.8 127.11 53.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.625 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -111.26 99.15 42.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.82 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.72 129.37 10.78 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.176 1.917 . . . . 0.0 112.752 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -81.09 3.25 23.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.565 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.8 15.42 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -77.87 95.64 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -71.67 -42.77 67.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.51 149.6 49.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.149 0.499 . . . . 0.0 111.53 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.59 HD13 HG12 ' A' ' 41' ' ' VAL . 58.5 tp -119.29 120.92 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.03 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 40' ' ' ILE . 85.0 mtp180 -109.9 139.58 44.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -116.83 126.68 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.787 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.08 122.42 21.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 9.4 p -72.51 -43.47 63.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.581 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.37 48.36 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.139 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.27 -25.63 26.03 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.318 2.012 . . . . 0.0 112.83 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.07 -40.3 87.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 30' ' ' SER . 92.0 m -117.3 119.77 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.714 0.292 . . . . 0.0 110.609 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.69 95.3 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -98.31 131.03 44.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.3 m -63.66 139.01 58.73 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.118 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.05 127.9 51.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.094 0.473 . . . . 0.0 112.227 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.35 129.09 75.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -131.34 138.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.253 0.549 . . . . 0.0 110.995 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 25' ' ' LEU . 31.2 m -112.81 149.76 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -116.31 120.02 37.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.27 153.62 23.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.665 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.5 p -59.7 -21.1 60.15 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.49 0.494 . . . . 0.0 112.122 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.52 7.27 17.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 110.91 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.2 20.62 66.82 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -101.78 127.55 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.647 0.26 . . . . 0.0 110.899 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -104.45 129.61 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.363 . . . . 0.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.66 140.68 49.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.22 131.86 44.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.421 HD22 ' CH2' ' A' ' 57' ' ' TRP . 82.0 mt -117.0 145.93 43.36 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.196 0.522 . . . . 0.0 111.691 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 45.1 t0 -97.1 117.12 66.05 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.35 -18.58 53.76 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 123.222 2.615 . . . . 0.0 113.913 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.26 -24.23 66.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 58' ' ' VAL . 77.1 mm-40 -81.87 135.12 35.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.062 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.04 -42.07 98.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.421 ' CH2' HD22 ' A' ' 51' ' ' LEU . 61.4 p-90 -62.87 -29.65 70.92 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 55' ' ' GLU . 57.8 t -64.45 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.71 -38.5 85.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.59 -39.37 90.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.199 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.6 t -61.0 -47.83 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.351 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.403 HG23 HD21 ' A' ' 25' ' ' LEU . 15.0 p -72.4 -41.96 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.02 -42.87 79.97 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.28 -41.6 73.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 32.0 m-85 -71.37 -37.19 71.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.023 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 m . . . . . 0 C--O 1.231 0.129 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.168 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.8 m -90.28 95.91 10.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.912 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -83.79 -27.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.569 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -130.07 143.66 50.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.431 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 52' ' ' ASP . 72.1 p -131.41 159.57 37.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 111.746 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.85 128.75 55.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -64.25 -37.27 86.88 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -128.36 72.77 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.65 159.56 48.46 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.493 2.129 . . . . 0.0 111.85 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.434 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 20.5 p90 -76.27 168.26 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -109.62 98.34 32.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.403 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 17' ' ' PHE . 3.2 Cg_exo -81.91 124.11 4.34 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.959 2.439 . . . . 0.0 112.479 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.14 -1.05 51.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.45 20.78 13.17 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.94 120.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.148 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -101.85 -35.8 8.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.532 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -132.14 144.35 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.728 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -127.02 110.79 13.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.24 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 40' ' ' ILE . 82.6 mtt85 -101.5 137.47 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.0 111.456 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -117.46 129.08 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.064 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.85 124.02 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.16 147.71 48.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 p -71.66 -53.01 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.5 -159.98 29.22 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.738 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.06 -24.13 4.11 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.043 1.829 . . . . 0.0 112.288 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -73.06 -39.96 65.46 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.85 131.84 55.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.754 0.311 . . . . 0.0 111.053 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.66 93.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.139 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -129.35 158.1 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.849 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.4 p -71.5 158.11 36.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.654 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -129.69 139.61 51.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.929 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 62' ' ' VAL . 87.3 mt -120.8 129.63 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.118 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.9 tt -128.73 135.64 61.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.05 0.452 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.577 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.1 m -112.78 148.08 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.0 110.765 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.37 124.14 49.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.855 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.01 159.3 17.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.731 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.3 p -59.56 -21.21 59.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.415 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.34 5.2 35.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.075 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 25.85 54.53 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.026 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -101.07 142.45 32.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.678 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -116.04 131.38 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 110.823 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -120.44 145.19 47.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.55 126.34 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 58' ' ' VAL . 84.7 mt -116.91 145.23 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' HB ' ' A' ' 12' ' ' THR . 45.4 t0 -108.59 113.74 59.64 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.72 -12.93 33.88 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.652 2.901 . . . . 0.0 115.514 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.04 -21.43 66.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.142 0.428 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -95.86 135.61 37.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.718 0.294 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 26.9 m120 -62.3 -39.03 91.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.503 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.44 -45.03 92.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.159 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 51' ' ' LEU . 63.4 t -62.52 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -61.41 -38.22 86.33 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.556 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 56' ' ' ASN . 27.4 mmm180 -59.96 -41.05 91.08 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.438 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 75.5 t -64.09 -46.51 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 77.8 t -63.72 -47.26 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.656 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.24 -38.94 92.86 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.417 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 47.6 m-85 -70.81 -36.53 73.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.71 0.29 . . . . 0.0 111.749 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 25' ' ' LEU . 88.3 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.312 -0.852 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 99.7 m . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.692 0.282 . . . . 0.0 111.241 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -61.86 -39.89 93.47 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.308 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.3 m -88.77 127.16 35.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.8 pt -104.01 -9.55 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -147.93 137.57 22.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.142 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.8 p -129.64 160.24 33.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 9.2 t80 -101.93 117.57 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -93.44 -12.44 29.77 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 35.4 mmtp -84.61 122.78 74.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.77 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HA ' ' CD2' ' A' ' 57' ' ' TRP . 74.4 Cg_exo -54.67 129.39 34.75 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.455 2.104 . . . . 0.0 112.794 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -160.93 137.17 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -119.4 90.64 42.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.78 124.38 11.83 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.556 2.171 . . . . 0.0 112.178 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -83.72 0.54 46.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.788 0.328 . . . . 0.0 111.452 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.83 14.22 29.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -75.22 119.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.938 0.399 . . . . 0.0 110.073 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -102.51 -42.96 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -130.41 149.69 51.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 111.478 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.41 HD13 HG12 ' A' ' 41' ' ' VAL . 65.9 tp -118.52 122.03 41.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.375 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' A' ' 40' ' ' ILE . 99.7 mtt180 -109.48 143.73 38.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.807 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.7 128.97 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.376 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 81.5 mt -104.43 123.24 58.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.45 139.36 47.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.9 p -71.19 -42.14 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.83 -170.51 36.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.591 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.43 -22.64 15.94 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.065 1.844 . . . . 0.0 112.316 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -71.14 -39.8 71.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' SER . 71.3 m -116.67 131.23 57.0 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.39 95.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.217 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -111.33 158.27 19.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.003 0.43 . . . . 0.0 111.783 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.8 p -83.11 166.38 18.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.465 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.496 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.5 mt-10 -125.24 143.44 50.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 110.986 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -117.49 127.92 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.997 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.5 tt -127.32 137.66 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.168 0.508 . . . . 0.0 110.537 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 25' ' ' LEU . 27.3 m -112.73 148.4 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.973 0.416 . . . . 0.0 110.745 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.66 123.14 48.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.75 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.99 153.92 20.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.5 p -60.07 -19.5 53.39 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.597 0.561 . . . . 0.0 112.17 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 3.98 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.93 56.72 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.233 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -101.46 139.19 37.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.872 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -117.44 129.29 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.672 0.272 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.421 ' O ' HG13 ' A' ' 40' ' ' ILE . 87.7 mt -120.51 135.9 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.629 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.86 123.95 46.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -117.29 148.04 42.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -87.72 118.4 69.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.134 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.56 -19.34 64.36 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.171 2.581 . . . . 0.0 113.853 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.18 -21.24 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.83 133.59 35.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.007 0.432 . . . . 0.0 111.02 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.35 -40.51 96.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . 0.49 ' CD2' ' HA ' ' A' ' 16' ' ' PRO . 56.7 p-90 -64.0 -30.35 71.43 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.644 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.17 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.043 0.449 . . . . 0.0 109.927 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.96 -40.0 91.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.317 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -63.05 -38.34 90.8 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.553 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.582 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 66.4 t -59.81 -47.57 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.377 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.06 -38.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.54 -44.63 77.87 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.65 -41.6 96.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 41.0 m-85 -70.9 -34.88 72.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 111.577 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.679 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 8.5 m . . . . . 0 CA--C 1.529 0.156 0 CA-C-O 120.72 0.295 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -63.37 -41.14 98.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.082 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.7 m -93.28 93.13 8.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.72 -44.34 98.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -116.43 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -130.12 158.46 39.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.413 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t80 -108.48 138.74 44.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 71.0 m -61.71 -41.45 97.62 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -131.8 72.84 79.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.2 Cg_endo -72.07 156.23 56.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.752 2.302 . . . . 0.0 113.358 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.47 131.01 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.843 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -100.83 107.43 49.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.656 0.265 . . . . 0.0 110.79 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.58 153.51 34.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.932 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.28 3.25 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.402 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -98.12 20.2 12.79 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.83 118.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -91.75 -45.74 8.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.72 149.07 52.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.779 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.6 tt -124.88 114.7 19.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.457 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -107.33 136.39 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.206 0.527 . . . . 0.0 111.482 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -117.35 127.74 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.954 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -108.49 121.39 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 110.719 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.22 144.28 50.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.83 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.8 p -72.17 -54.48 9.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.68 -165.09 25.1 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.113 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.93 -29.14 8.68 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.676 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -71.48 -38.38 71.24 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 t -113.53 128.46 56.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.742 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.58 93.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -127.31 139.97 52.52 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -64.72 137.64 57.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.595 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.2 mt-10 -125.56 140.9 52.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 130.73 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 48' ' ' GLU . 20.5 tt -128.58 141.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.496 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.4 m -114.57 149.46 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 111.042 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -110.6 122.34 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.178 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 47' ' ' ARG . 82.0 mt -90.27 153.17 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.7 p -60.57 -19.88 58.82 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.69 0.619 . . . . 0.0 112.124 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -85.13 4.22 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.94 58.93 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.324 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB2' HD12 ' A' ' 43' ' ' LEU . 96.5 mtt-85 -101.26 158.81 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.545 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.3 mt-10 -128.1 133.33 49.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.4 mt -123.9 142.54 51.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.215 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.8 m -100.12 133.14 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.71 148.34 39.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -98.64 110.41 56.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.49 -14.3 36.73 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.086 2.524 . . . . 0.0 113.54 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -61.68 -37.08 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 14' ' ' SER . 77.5 mm-40 -77.29 127.88 33.37 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.84 -40.34 97.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -64.52 -32.8 74.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.87 -43.23 97.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -61.22 -41.41 96.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.51 -46.0 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.601 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.65 -49.2 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.77 -43.06 89.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.0 -40.04 83.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.978 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -62.37 -48.59 79.08 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.943 -179.521 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.5 m . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.5 0.19 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -62.27 -40.86 97.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.066 0.46 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.2 m -105.99 105.46 15.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.1 mt -63.24 -47.2 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.845 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.631 ' HG3' HG22 ' A' ' 10' ' ' ILE . 64.4 mttp -132.21 149.01 52.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 111.303 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 p -129.8 156.92 43.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.128 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 35.9 t80 -108.7 142.46 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.6 p -62.04 -35.64 79.21 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.58 73.53 80.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.505 0.193 . . . . 0.0 110.964 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.31 156.74 54.57 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.652 2.235 . . . . 0.0 113.159 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -86.88 143.54 27.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.105 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.535 ' CG ' HG11 ' A' ' 61' ' ' VAL . 95.5 m-70 -119.06 90.95 42.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.22 147.74 94.47 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.195 2.597 . . . . 0.0 112.582 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -81.06 3.27 23.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -96.52 16.37 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.892 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.1 mt -76.06 118.38 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.74 -44.34 8.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -130.62 149.18 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.4 tt -124.42 115.91 21.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -108.31 132.23 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.32 0.581 . . . . 0.0 112.046 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.8 t -122.49 128.47 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.381 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.1 148.63 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.105 0.479 . . . . 0.0 111.776 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.95 148.95 36.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.084 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 79.5 p -70.59 -40.56 73.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.713 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.88 -156.62 36.27 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.922 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.87 -20.09 7.91 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.167 1.911 . . . . 0.0 112.217 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -70.76 -40.18 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.498 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' SER . 97.6 m -124.48 149.08 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.67 -4.58 55.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.05 139.9 41.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 111.6 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.6 m -64.62 137.41 57.82 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.083 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.99 132.89 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 111.753 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -117.53 130.28 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -132.15 144.18 37.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 110.896 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.7 m -115.16 149.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.759 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -114.37 119.54 37.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.423 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.63 153.18 20.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.0 p -60.53 -20.13 59.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.063 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.52 4.09 37.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.839 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.11 22.46 57.25 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.22 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -100.89 144.15 30.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.318 . . . . 0.0 111.118 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.6 mt-10 -121.29 130.28 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.4 141.7 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 87.5 m -97.06 134.64 40.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.392 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.28 144.15 44.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.778 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -96.55 116.51 66.16 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.06 -13.25 39.17 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.291 2.66 . . . . 0.0 113.946 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.52 -38.43 87.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -79.63 127.66 32.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.751 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -69.19 -35.62 76.45 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -65.21 -31.81 73.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.635 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.6 -42.11 94.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -61.78 -38.24 87.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.59 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -60.48 -41.31 93.97 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.888 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.535 HG11 ' CG ' ' A' ' 18' ' ' HIS . 78.8 t -65.1 -44.33 95.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.292 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -61.47 -47.13 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.843 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.45 -39.58 94.1 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.357 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.24 -46.03 92.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.284 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -68.1 -38.15 81.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.436 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.171 179.915 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 120.912 0.387 . . . . 0.0 110.838 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.61 153.12 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.731 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.95 17.51 16.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.33 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -64.74 -26.7 68.48 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.475 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.2 mt -68.79 139.48 55.28 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.997 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.5 140.69 22.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.566 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.531 ' HA ' ' OE2' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -88.06 80.2 7.75 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.451 179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.3 tt0 -62.58 -41.13 98.76 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.586 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 96.4 m -93.58 87.95 5.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.969 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.27 -43.94 98.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.255 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -121.42 149.09 43.53 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.27 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 75.6 p -127.28 158.63 36.68 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.77 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -89.82 117.96 29.06 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.2 p -94.94 -19.71 20.01 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -75.02 129.73 82.4 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.818 -0.174 . . . . 0.0 110.579 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -55.26 129.05 33.14 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.46 2.107 . . . . 0.0 112.916 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 69.4 t80 -160.06 125.17 3.96 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.506 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -122.51 89.31 49.56 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.284 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -77.91 134.55 13.38 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.223 1.949 . . . . 0.0 112.577 179.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -80.72 3.14 23.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.725 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -94.06 8.5 41.25 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 84.5 mt -82.16 119.31 31.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.264 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -108.17 -34.95 6.7 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.031 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -140.0 159.55 41.93 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.244 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -146.83 144.29 29.21 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.724 0.297 . . . . 0.0 110.296 179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.6 mtm105 -119.74 145.01 46.94 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.215 0.531 . . . . 0.0 111.468 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.7 t -117.07 126.9 74.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.535 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.5 mt -109.19 124.82 66.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 120.732 0.301 . . . . 0.0 110.709 -179.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.32 129.53 39.57 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.264 -0.426 . . . . 0.0 109.92 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.701 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 3.6 p -72.98 -53.17 11.89 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.173 -0.467 . . . . 0.0 112.152 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.15 -165.65 42.35 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.98 -0.628 . . . . 0.0 112.355 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -61.19 -34.98 87.82 Favored 'Trans proline' 0 CA--C 1.533 0.451 0 C-N-CA 123.039 2.493 . . . . 0.0 113.259 178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 68.5 m80 -64.78 -40.53 95.41 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -178.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.701 ' O ' ' HB2' ' A' ' 30' ' ' SER . 94.8 m -118.1 124.68 48.64 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.767 -0.373 . . . . 0.0 111.278 -179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.59 -40.07 96.01 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -106.37 142.34 36.21 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 112.448 0.536 . . . . 0.0 112.448 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 49.3 m -67.81 138.28 56.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 115.54 -0.754 . . . . 0.0 109.865 178.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.531 ' OE2' ' HA ' ' A' ' 7' ' ' CYS . 46.5 mt-10 -104.48 125.47 50.68 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.4 mt -118.42 128.66 75.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.652 HD11 ' HB3' ' A' ' 48' ' ' GLU . 21.2 tt -132.38 141.58 44.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.077 0.465 . . . . 0.0 110.867 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 30.0 m -115.17 151.54 16.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.035 0.445 . . . . 0.0 110.777 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -113.56 122.59 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.665 -179.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -91.4 153.54 19.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.903 -0.589 . . . . 0.0 110.182 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -21.93 62.47 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.304 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.6 t0 -85.49 10.47 12.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.646 0.26 . . . . 0.0 110.729 179.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.61 25.88 64.3 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.444 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.8 mmt-85 -101.62 145.72 28.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.823 0.344 . . . . 0.0 111.175 -179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.652 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -117.83 135.08 54.31 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.745 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 65.0 tp -128.41 128.19 43.99 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.326 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.3 m -91.83 129.82 37.72 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 120.945 0.403 . . . . 0.0 110.397 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.3 mt -116.37 145.84 42.92 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.953 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 37.1 t0 -92.22 118.75 68.28 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.164 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.67 -20.63 69.66 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 123.119 2.546 . . . . 0.0 113.936 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -68.91 -20.99 64.25 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.592 0.234 . . . . 0.0 111.608 179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -83.28 132.55 35.02 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.071 0.462 . . . . 0.0 111.083 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -61.91 -42.76 99.46 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.805 -0.634 . . . . 0.0 112.182 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 60.8 p-90 -62.36 -29.96 70.84 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -63.8 -42.71 96.81 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-O 121.024 0.44 . . . . 0.0 109.895 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.1 tp60 -61.72 -38.68 88.78 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.725 178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.9 mtp85 -61.47 -40.14 93.46 Favored 'General case' 0 C--O 1.224 -0.258 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.288 179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.482 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.8 t -61.27 -48.65 87.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.819 0.342 . . . . 0.0 110.335 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 70.2 t -65.67 -48.13 83.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.694 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.92 -46.94 79.55 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.5 mmtt -65.72 -41.69 91.96 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.482 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 33.0 m-85 -71.31 -36.3 71.56 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 121.075 -0.25 . . . . 0.0 111.663 179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.3 mt . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.212 -0.899 . . . . 0.0 111.051 179.743 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 CA-C-O 120.963 0.411 . . . . 0.0 110.892 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.94 153.85 39.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.691 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -93.39 11.63 27.67 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.24 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -62.92 -37.09 85.6 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.555 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.7 tt -66.9 120.46 13.63 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.941 0.401 . . . . 0.0 111.116 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 57.3 mmm-85 -131.86 159.07 39.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.176 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.6 m -74.11 123.75 25.02 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.94 -0.392 . . . . 0.0 109.94 179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -64.48 -41.06 96.69 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 120.898 0.38 . . . . 0.0 111.573 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 80.2 m -97.56 127.21 43.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.655 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.8 pt -107.61 -27.74 2.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.798 0.333 . . . . 0.0 111.133 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 60.0 mtmt -133.79 143.21 48.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.3 p -132.13 158.8 40.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.896 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 15.7 p90 -108.86 143.51 37.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.916 0.388 . . . . 0.0 110.946 179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.4 p -90.6 -11.01 41.24 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.652 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -78.95 124.46 84.82 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.831 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo -55.91 133.66 59.38 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.874 2.382 . . . . 0.0 113.191 179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 46.3 t80 -154.6 111.62 3.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.619 -0.718 . . . . 0.0 109.695 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -136.33 89.03 19.91 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 120.878 0.371 . . . . 0.0 111.792 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -61.65 142.36 94.1 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.759 2.306 . . . . 0.0 112.379 179.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 59.5 mtmt -81.67 2.55 29.08 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.037 179.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.61 14.7 27.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 0.0 112.21 -178.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 91.1 mt -73.74 119.12 20.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.163 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -89.53 -48.73 7.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.972 -179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.78 150.48 49.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.965 0.412 . . . . 0.0 111.155 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.3 tt -119.18 116.6 26.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.184 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 80.4 mtt85 -106.68 144.62 33.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.406 0.622 . . . . 0.0 112.011 179.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.9 t -115.58 128.79 72.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.613 179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.9 mt -106.29 127.0 61.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 120.874 0.368 . . . . 0.0 111.08 -178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -67.12 142.26 57.14 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.032 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.608 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 78.5 p -70.74 -41.49 71.75 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 72.0 -174.34 43.73 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.533 -179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.79 -31.32 10.49 Favored 'Trans proline' 0 CA--C 1.534 0.483 0 C-N-CA 122.042 1.828 . . . . 0.0 112.986 178.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 76.3 m80 -71.72 -38.56 70.49 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -178.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.608 ' O ' ' HB2' ' A' ' 30' ' ' SER . 79.0 m -105.58 119.44 39.13 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.055 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.35 -39.76 94.53 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 112.068 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -106.62 146.36 30.8 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.625 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.9 p -74.01 162.91 28.54 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.589 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -125.55 137.73 53.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 111.556 -178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.9 mt -117.67 128.69 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.607 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.4 tt -129.98 138.0 55.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.207 0.527 . . . . 0.0 111.028 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.573 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.9 m -114.74 148.42 17.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.117 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -112.83 121.96 46.23 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.582 HD12 ' HB2' ' A' ' 47' ' ' ARG . 87.0 mt -87.57 152.45 22.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.223 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.8 m -59.78 -24.93 64.51 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.878 -179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.3 t0 -80.43 7.58 9.47 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.139 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.48 22.01 63.24 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.648 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.582 ' HB2' HD12 ' A' ' 43' ' ' LEU . 57.5 mmm-85 -101.76 147.45 26.45 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.734 0.302 . . . . 0.0 111.192 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.607 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.1 mt-10 -118.95 132.82 56.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.864 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.405 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 87.9 mt -120.96 145.43 47.73 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.676 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.6 t -105.07 128.67 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.116 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 90.3 mt -116.22 142.1 47.27 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.063 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 53' ' ' PRO . 41.1 t0 -92.9 116.3 66.28 Favored Pre-proline 0 CA--C 1.53 0.211 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.401 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 52' ' ' ASP . 28.8 Cg_endo -61.61 -18.89 62.57 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.071 2.514 . . . . 0.0 113.835 -178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -68.1 -21.66 64.94 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.588 0.232 . . . . 0.0 111.565 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.436 ' HB2' HG23 ' A' ' 58' ' ' VAL . 76.6 mm-40 -84.66 132.43 34.48 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.15 -40.24 95.32 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.835 -0.62 . . . . 0.0 112.086 -179.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.478 ' O ' HG23 ' A' ' 61' ' ' VAL . 68.5 p-90 -63.19 -30.69 71.79 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 111.704 0.261 . . . . 0.0 111.704 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 55' ' ' GLU . 53.4 t -63.46 -43.69 98.51 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.413 179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.97 -42.11 97.68 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.388 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 90.5 mmt-85 -62.76 -41.13 99.08 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.314 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 57' ' ' TRP . 64.4 t -63.17 -46.63 95.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.751 179.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 71.3 t -62.36 -47.51 92.69 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.211 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -66.07 -40.97 91.32 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.613 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -62.3 -49.08 77.05 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.869 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.406 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 48.8 m-85 -71.57 -37.12 71.07 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.476 179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 12.5 tp . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.052 -0.975 . . . . 0.0 111.244 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.473 0 CA-C-O 121.113 0.483 . . . . 0.0 110.901 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.34 70.54 10.83 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.069 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' HA ' ' NE2' ' A' ' 33' ' ' HIS . 57.6 mtpt -96.42 4.84 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.128 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -93.3 9.83 34.6 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.081 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.4 mt -71.83 138.77 48.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.155 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 90.7 mtm180 -130.95 135.48 47.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.28 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 24.4 m -97.84 81.11 2.83 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -64.62 -40.1 94.88 Favored 'General case' 0 N--CA 1.465 0.303 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.685 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 91.6 m -92.97 87.32 5.73 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.477 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.44 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.4 mt -63.25 -44.96 99.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 121.104 0.478 . . . . 0.0 110.227 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG3' HG22 ' A' ' 10' ' ' ILE . 68.8 mttm -127.66 147.75 50.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.943 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 68.3 p -128.15 158.84 36.95 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.848 0.356 . . . . 0.0 111.187 -179.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 2.2 p90 -108.8 158.35 17.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.996 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 88.3 p -91.06 -3.43 57.18 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -179.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -127.51 73.25 77.98 Favored Pre-proline 0 N--CA 1.465 0.296 0 CA-C-O 120.681 0.277 . . . . 0.0 111.6 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.38 161.79 34.3 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.973 2.449 . . . . 0.0 113.319 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -121.23 130.04 53.48 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.488 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.402 ' CG ' HG11 ' A' ' 61' ' ' VAL . 94.8 m-70 -112.88 98.05 43.85 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-O 120.716 0.293 . . . . 0.0 111.4 -179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -77.08 155.25 33.47 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.819 2.346 . . . . 0.0 112.615 179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.1 pttp -80.07 3.66 19.62 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.502 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -96.62 17.54 16.17 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 112.501 0.556 . . . . 0.0 112.501 -178.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 80.4 mt -75.58 121.66 27.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -94.04 -47.49 6.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.913 -179.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -131.07 147.42 52.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.55 ' HG ' HG12 ' A' ' 41' ' ' VAL . 2.2 tt -119.53 112.51 19.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.893 179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 96.4 mtt-85 -110.19 147.55 33.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.244 0.545 . . . . 0.0 111.375 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 29.8 m -126.96 150.67 33.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.607 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.3 mt -119.86 124.64 73.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.612 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -68.75 138.99 55.3 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' HA ' ' HB2' ' A' ' 34' ' ' CYS . 2.2 p -72.16 -55.12 7.8 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.881 -0.328 . . . . 0.0 111.814 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.16 -154.22 20.13 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.94 -0.648 . . . . 0.0 112.113 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.5 -25.69 3.63 Favored 'Trans proline' 0 CA--C 1.534 0.478 0 C-N-CA 122.233 1.955 . . . . 0.0 112.772 178.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.454 ' NE2' ' HA ' ' A' ' 3' ' ' LYS . 84.6 m-70 -71.08 -40.19 71.71 Favored 'General case' 0 N--CA 1.465 0.293 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -178.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.403 ' HB2' ' HA ' ' A' ' 30' ' ' SER . 74.6 m -113.46 131.7 55.93 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.791 0.329 . . . . 0.0 110.927 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.13 -39.34 92.23 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.341 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -131.14 149.29 52.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.87 0.367 . . . . 0.0 111.782 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.415 ' O ' ' HG3' ' A' ' 53' ' ' PRO . 59.2 m -64.05 138.57 58.52 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.984 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 83.6 mt-10 -116.94 139.76 50.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.84 0.352 . . . . 0.0 111.677 -178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 84.8 mt -118.34 129.97 73.88 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.104 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.649 HD11 ' HB3' ' A' ' 48' ' ' GLU . 17.7 tt -131.66 135.9 58.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.27 0.557 . . . . 0.0 110.932 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.55 HG12 ' HG ' ' A' ' 25' ' ' LEU . 18.0 m -112.98 149.12 15.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 C-N-CA 120.581 -0.447 . . . . 0.0 110.86 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -112.89 123.2 49.78 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.721 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 80.7 mt -86.94 154.79 20.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.073 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.3 p -60.04 -19.64 53.88 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.567 0.542 . . . . 0.0 112.131 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -86.52 5.27 36.21 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.008 179.413 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 82.49 23.15 57.16 Favored Glycine 0 C--N 1.335 0.493 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.267 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 10.7 mpt_? -99.75 148.08 24.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.822 0.344 . . . . 0.0 111.139 -179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.649 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.3 mt-10 -118.83 131.8 56.09 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.048 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.401 ' HB2' ' CG2' ' A' ' 41' ' ' VAL . 88.9 mt -120.67 143.89 48.48 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.669 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.1 t -98.75 128.45 44.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.094 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 86.4 mt -115.61 143.31 45.54 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.054 0.454 . . . . 0.0 111.408 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -95.87 113.97 63.15 Favored Pre-proline 0 CA--C 1.532 0.285 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.708 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.415 ' HG3' ' O ' ' A' ' 37' ' ' THR . 54.4 Cg_endo -67.78 -15.87 45.0 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 123.19 2.593 . . . . 0.0 113.638 -179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.74 -37.66 85.06 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.641 -0.254 . . . . 0.0 111.398 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.3 mm-40 -74.17 126.22 30.1 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-O 121.043 0.449 . . . . 0.0 110.692 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -62.78 -41.37 99.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.715 -0.675 . . . . 0.0 112.52 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.5 p-90 -63.19 -30.47 71.61 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 121.131 -0.227 . . . . 0.0 111.366 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.2 t -63.1 -44.5 99.52 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 121.067 0.46 . . . . 0.0 109.768 178.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -62.11 -39.24 91.87 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.324 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 77.5 mtp85 -60.9 -42.28 97.73 Favored 'General case' 0 C--N 1.334 -0.083 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.402 HG11 ' CG ' ' A' ' 18' ' ' HIS . 74.6 t -66.83 -44.57 88.98 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.88 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 62.4 t -61.93 -48.17 89.82 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.392 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -65.16 -41.13 95.0 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.743 0.306 . . . . 0.0 110.748 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -63.65 -43.66 96.11 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.937 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -61.33 -47.02 87.81 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.062 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 89.3 mt . . . . . 0 C--O 1.25 1.106 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.105 -179.893 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 120.948 0.404 . . . . 0.0 110.889 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.93 -39.29 91.53 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.877 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -74.62 -11.3 60.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.508 -0.314 . . . . 0.0 111.689 -179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -92.72 1.74 57.11 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.158 0.504 . . . . 0.0 110.257 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.445 HD21 ' O ' ' A' ' 30' ' ' SER . 68.4 tp -87.67 122.7 31.68 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.751 -0.658 . . . . 0.0 110.827 -179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 20.6 ptp180 -149.67 163.1 38.83 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.321 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 19.6 m -92.57 96.31 10.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.131 -0.322 . . . . 0.0 110.131 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -64.75 -39.97 94.51 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 121.113 0.482 . . . . 0.0 111.534 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 74.9 m -93.21 92.47 7.75 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.513 -178.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.411 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.3 mt -63.69 -45.02 98.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.232 0.539 . . . . 0.0 110.219 178.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.411 ' HG3' HG22 ' A' ' 10' ' ' ILE . 58.6 mtmt -128.18 148.52 50.61 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 72.2 p -128.46 158.92 37.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.827 0.346 . . . . 0.0 111.033 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.473 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 47.1 t80 -108.15 142.4 38.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.992 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.43 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 80.7 p -62.18 -36.34 81.6 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -129.05 71.64 81.98 Favored Pre-proline 0 CA--C 1.533 0.297 0 O-C-N 122.175 -0.328 . . . . 0.0 111.776 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.94 156.23 52.54 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.446 2.097 . . . . 0.0 112.55 179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 85.5 t80 -87.79 119.92 28.6 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.459 ' NE2' HD13 ' A' ' 22' ' ' ILE . 22.2 t-160 -116.24 100.72 53.7 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.937 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -62.15 139.64 79.37 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.005 2.47 . . . . 0.0 112.448 178.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 64.2 mttp -82.13 0.56 40.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.452 179.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -100.58 17.83 20.75 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.522 HG22 HD22 ' A' ' 43' ' ' LEU . 39.6 pt -66.83 147.86 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.051 0.453 . . . . 0.0 111.154 179.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -100.57 -29.81 12.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.458 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -139.39 148.49 42.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.224 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.765 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.8 tt -128.99 106.85 9.16 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.642 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.487 ' HB3' HG23 ' A' ' 40' ' ' ILE . 32.4 tpt180 -100.24 128.05 46.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.236 0.541 . . . . 0.0 111.477 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 63.0 t -112.68 125.72 69.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.53 124.59 71.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 CA-C-O 121.116 0.484 . . . . 0.0 111.635 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -78.14 154.86 30.84 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.654 178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 37' ' ' THR . 77.6 p -70.43 -42.91 70.96 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.917 -0.313 . . . . 0.0 111.794 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.98 -162.12 31.94 Favored Glycine 0 CA--C 1.521 0.468 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.38 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -82.7 -16.18 7.97 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 122.727 2.285 . . . . 0.0 114.222 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -104.79 -2.07 25.29 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.163 1.172 . . . . 0.0 114.163 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.509 ' HB3' ' O ' ' A' ' 30' ' ' SER . 41.3 t -127.73 132.75 49.56 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 121.724 -0.61 . . . . 0.0 110.587 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -61.87 -39.81 93.18 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -141.85 156.47 45.53 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.226 0.454 . . . . 0.0 112.226 -178.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 30' ' ' SER . 74.5 p -74.33 161.9 29.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.547 179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -149.69 149.55 30.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.072 0.463 . . . . 0.0 111.702 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.1 mt -119.76 129.05 75.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.513 179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.662 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.2 tt -128.49 137.25 57.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 0.0 110.645 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.765 HG12 ' HG ' ' A' ' 25' ' ' LEU . 26.8 m -115.42 152.68 17.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.855 0.36 . . . . 0.0 110.622 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -118.74 123.53 45.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.377 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.522 HD22 HG22 ' A' ' 22' ' ' ILE . 2.3 mm? -87.41 157.95 19.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.142 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 82.6 p -59.95 -21.19 60.87 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.655 0.597 . . . . 0.0 112.453 -178.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -88.0 6.7 34.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.62 -0.263 . . . . 0.0 110.92 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.07 23.61 58.96 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.082 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -99.0 128.33 45.12 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 -178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.662 ' HB3' HD11 ' A' ' 40' ' ' ILE . 99.9 mt-10 -104.74 130.64 52.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.834 0.349 . . . . 0.0 111.043 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 97.1 mt -119.4 144.48 46.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.097 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 51.3 t -100.75 127.9 47.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.427 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 87.3 mt -112.51 145.52 40.12 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.76 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -87.23 114.59 59.3 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.707 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -69.09 -17.96 40.37 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.966 2.444 . . . . 0.0 113.438 -179.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -70.19 -21.43 63.04 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.43 ' HG3' ' O ' ' A' ' 14' ' ' SER . 81.1 mm-40 -85.7 126.37 33.9 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.966 0.412 . . . . 0.0 110.899 -179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.88 -40.52 97.78 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.652 -178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 44.6 p-90 -63.33 -34.11 76.99 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 120.787 -0.365 . . . . 0.0 111.295 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 66.0 t -64.86 -44.41 96.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 CA-C-O 120.95 0.405 . . . . 0.0 110.144 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 9.7 tp-100 -62.23 -39.87 94.27 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.069 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -61.2 -41.63 97.17 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.363 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.5 t -67.45 -44.49 86.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.272 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.0 t -62.23 -47.43 93.12 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.402 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -64.16 -39.78 94.74 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.835 0.35 . . . . 0.0 110.474 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -61.64 -44.98 95.96 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.853 179.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -67.27 -39.21 86.05 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.595 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.319 -0.848 . . . . 0.0 111.176 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.653 0.263 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 60.32 43.78 13.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.967 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -92.4 1.62 57.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.19 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 79.7 mm-40 60.04 39.44 19.84 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.206 0.527 . . . . 0.0 110.893 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.443 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 68.8 tp -109.66 123.68 49.89 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.264 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 96.2 mtm-85 -128.98 147.25 50.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.578 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.5 m -87.74 89.9 8.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 26.2 pt20 -67.81 -23.19 65.16 Favored 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 75.9 m -97.89 85.01 3.43 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.739 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 47.7 mm -67.56 -45.39 85.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.498 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 64.7 mttp -130.24 145.05 51.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.216 179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.6 p -130.58 158.99 38.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.734 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 39.6 t80 -92.47 140.61 29.39 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 71.3 m -61.01 -39.6 90.35 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 112.782 0.66 . . . . 0.0 112.782 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -127.04 76.12 76.23 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.981 -0.287 . . . . 0.0 111.565 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -71.83 158.93 51.92 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.61 2.207 . . . . 0.0 112.73 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -99.18 140.23 33.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.423 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -111.6 99.98 46.47 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.51 -0.313 . . . . 0.0 111.09 -179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.04 145.92 96.41 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.079 2.519 . . . . 0.0 112.644 179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.9 tttm -80.01 3.17 20.99 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.202 0.525 . . . . 0.0 110.821 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.18 20.88 12.7 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.2 -0.455 . . . . 0.0 112.195 -178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 65' ' ' PHE . 83.9 mt -75.72 120.41 25.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.778 0.323 . . . . 0.0 110.152 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -89.02 -47.09 8.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.846 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -133.86 149.18 51.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.948 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -120.55 115.21 22.99 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.746 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.49 ' HB2' HG23 ' A' ' 40' ' ' ILE . 41.1 mmt180 -104.97 142.8 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.203 0.525 . . . . 0.0 111.523 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.5 t -116.75 128.44 74.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.93 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 80.6 mt -108.42 123.88 64.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.929 0.395 . . . . 0.0 111.009 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.41 146.49 46.94 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.147 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.8 p -70.79 -42.81 69.84 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.08 -162.73 26.93 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.746 -0.74 . . . . 0.0 111.735 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -80.35 -24.91 5.07 Favored 'Trans proline' 0 CA--C 1.532 0.408 0 C-N-CA 122.038 1.825 . . . . 0.0 112.385 178.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 95.1 m-70 -71.75 -39.41 70.03 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 30' ' ' SER . 83.3 m -113.9 131.15 56.39 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.73 0.3 . . . . 0.0 111.618 -178.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.5 -40.0 95.91 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.816 179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.7 p-10 -118.56 159.04 24.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.316 -179.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 81.6 p -79.45 164.5 23.91 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -129.08 139.62 51.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.862 0.363 . . . . 0.0 111.245 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 85.3 mt -115.68 127.56 73.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 178.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.602 HD11 ' HB3' ' A' ' 48' ' ' GLU . 18.6 tt -129.66 138.22 54.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.289 0.566 . . . . 0.0 111.119 -179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.51 HG12 ' HG ' ' A' ' 25' ' ' LEU . 29.3 m -115.05 147.33 18.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.491 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -109.45 117.51 34.21 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.264 -179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 47' ' ' ARG . 87.8 mt -86.34 153.7 21.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.281 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 67.0 m -57.04 -34.24 68.03 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 123.821 0.7 . . . . 0.0 111.678 -178.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -74.57 6.78 3.48 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.615 179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.69 22.98 60.87 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.666 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.598 ' HB3' HD12 ' A' ' 43' ' ' LEU . 41.4 ttm180 -101.11 142.19 32.91 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.848 0.356 . . . . 0.0 111.061 -178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.602 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -116.34 131.65 56.89 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.881 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 88.7 mt -121.36 146.05 47.26 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.936 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 54.1 t -102.92 126.3 50.02 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 84.7 mt -109.57 145.35 36.51 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.731 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -90.11 114.46 60.98 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 115.848 -0.614 . . . . 0.0 111.06 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -68.81 -16.76 41.92 Favored 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.048 2.499 . . . . 0.0 113.318 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -62.12 -37.23 84.35 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.425 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.24 121.76 23.38 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 120.932 0.396 . . . . 0.0 110.674 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.78 -40.01 95.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.772 -178.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 34.9 p-90 -63.93 -31.66 72.92 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 120.978 -0.289 . . . . 0.0 111.315 -178.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 57.6 t -63.09 -43.85 99.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.4 tt0 -62.41 -38.85 91.29 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.382 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -60.97 -42.09 97.65 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.078 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 76.8 t -65.43 -44.37 94.41 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.383 178.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.4 t -61.94 -47.25 94.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.153 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.523 ' O ' ' HG ' ' A' ' 66' ' ' LEU . 98.7 mt-10 -64.58 -41.45 96.25 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 120.836 0.351 . . . . 0.0 110.539 179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -64.01 -43.93 94.16 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.111 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 22' ' ' ILE . 77.7 t80 -61.33 -46.89 88.36 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.095 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 63' ' ' GLU . 29.3 mt . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.459 -0.782 . . . . 0.0 111.329 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 120.955 0.407 . . . . 0.0 110.861 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.62 153.44 39.39 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.707 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -99.8 17.27 21.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.194 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -62.74 -37.76 87.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.82 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.5 mt -75.52 121.77 22.87 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.109 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -137.62 148.58 45.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.613 179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -86.31 97.92 10.67 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -63.48 -39.57 94.79 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.845 -0.616 . . . . 0.0 112.413 -178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 72.6 m -99.92 98.9 9.62 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 97.1 mt -65.16 -43.46 95.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 121.319 0.58 . . . . 0.0 109.888 178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -124.29 152.77 42.65 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.06 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.448 ' OG1' ' HB2' ' A' ' 52' ' ' ASP . 70.1 p -126.36 158.5 35.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.235 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.517 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 11.6 t80 -81.3 118.39 22.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.781 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 79.5 p -98.66 -15.18 19.51 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 -178.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.517 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 60.3 mtpt -72.38 131.01 85.25 Favored Pre-proline 0 N--CA 1.465 0.284 0 CA-C-O 120.496 0.188 . . . . 0.0 110.951 -179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -69.77 71.7 1.5 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 123.255 2.636 . . . . 0.0 113.863 -179.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -118.8 127.11 53.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.771 -0.649 . . . . 0.0 109.625 178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 57.0 m80 -111.26 99.15 42.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.62 -0.264 . . . . 0.0 110.82 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -76.72 129.37 10.78 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.176 1.917 . . . . 0.0 112.752 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -81.09 3.25 23.99 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.565 179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -97.8 15.42 23.77 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -178.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 81.9 mt -77.87 95.64 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.219 0 CA-C-O 121.177 0.513 . . . . 0.0 110.148 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -71.67 -42.77 67.07 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.387 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -135.51 149.6 49.54 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 121.149 0.499 . . . . 0.0 111.53 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.59 HD13 HG12 ' A' ' 41' ' ' VAL . 58.5 tp -119.29 120.92 38.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.03 179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.597 ' HB2' HG23 ' A' ' 40' ' ' ILE . 85.0 mtp180 -109.9 139.58 44.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.246 0.546 . . . . 0.0 111.365 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -116.83 126.68 74.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.787 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 47.0 mm -109.78 123.27 65.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 120.867 0.365 . . . . 0.0 110.886 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -73.08 122.42 21.77 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.063 179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.618 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 9.4 p -72.51 -43.47 63.56 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.581 -179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.5 -164.37 48.36 Favored Glycine 0 CA--C 1.52 0.364 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.139 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -70.27 -25.63 26.03 Favored 'Trans proline' 0 CA--C 1.532 0.395 0 C-N-CA 122.318 2.012 . . . . 0.0 112.83 178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.3 m80 -67.07 -40.3 87.0 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.618 ' O ' ' HB2' ' A' ' 30' ' ' SER . 92.0 m -117.3 119.77 36.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.714 0.292 . . . . 0.0 110.609 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.27 -39.69 95.3 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -98.31 131.03 44.96 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 46.3 m -63.66 139.01 58.73 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.118 178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -104.05 127.9 51.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.094 0.473 . . . . 0.0 112.227 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.3 mt -118.35 129.09 75.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 178.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.634 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -131.34 138.59 52.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.253 0.549 . . . . 0.0 110.995 -179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.59 HG12 HD13 ' A' ' 25' ' ' LEU . 31.2 m -112.81 149.76 15.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.548 -179.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -116.31 120.02 37.56 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.908 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 88.0 mt -84.27 153.62 23.46 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.665 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.5 p -59.7 -21.1 60.15 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.49 0.494 . . . . 0.0 112.122 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -83.52 7.27 17.62 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 120.702 0.287 . . . . 0.0 110.91 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 80.2 20.62 66.82 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.556 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 24.3 tpp180 -101.78 127.55 48.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.647 0.26 . . . . 0.0 110.899 -178.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.634 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -104.45 129.61 52.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.861 0.363 . . . . 0.0 110.994 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 87.8 mt -118.66 140.68 49.53 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.344 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.0 m -98.22 131.86 44.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.819 0.342 . . . . 0.0 111.187 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.421 HD22 ' CH2' ' A' ' 57' ' ' TRP . 82.0 mt -117.0 145.93 43.36 Favored 'General case' 0 C--O 1.238 0.488 0 CA-C-O 121.196 0.522 . . . . 0.0 111.691 -179.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' HB2' ' OG1' ' A' ' 12' ' ' THR . 45.1 t0 -97.1 117.12 66.05 Favored Pre-proline 0 CA--C 1.532 0.264 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.996 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -60.35 -18.58 53.76 Favored 'Trans proline' 0 N--CA 1.479 0.644 0 C-N-CA 123.222 2.615 . . . . 0.0 113.913 -178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.26 -24.23 66.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.554 0.216 . . . . 0.0 111.43 179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.433 ' HB2' HG23 ' A' ' 58' ' ' VAL . 77.1 mm-40 -81.87 135.12 35.45 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 120.896 0.379 . . . . 0.0 111.062 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -62.04 -42.07 98.79 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 115.912 -0.585 . . . . 0.0 112.135 -179.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.421 ' CH2' HD22 ' A' ' 51' ' ' LEU . 61.4 p-90 -62.87 -29.65 70.92 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 111.798 0.295 . . . . 0.0 111.798 -179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.433 HG23 ' HB2' ' A' ' 55' ' ' GLU . 57.8 t -64.45 -40.51 89.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 178.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 -60.71 -38.5 85.26 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.689 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 84.2 mtp180 -61.59 -39.37 90.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.199 178.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.436 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 69.6 t -61.0 -47.83 91.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.351 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.403 HG23 HD21 ' A' ' 25' ' ' LEU . 15.0 p -72.4 -41.96 64.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 -179.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 79.6 mm-40 -68.02 -42.87 79.97 Favored 'General case' 0 N--CA 1.465 0.283 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -70.28 -41.6 73.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.436 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 32.0 m-85 -71.37 -37.19 71.64 Favored 'General case' 0 N--CA 1.465 0.316 0 N-CA-C 111.683 0.253 . . . . 0.0 111.683 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 90.5 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.313 -0.851 . . . . 0.0 111.023 179.936 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 120.849 0.357 . . . . 0.0 110.865 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.72 -39.77 92.69 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.861 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -92.26 4.96 52.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.383 -0.372 . . . . 0.0 111.336 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 59.56 39.06 21.98 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.214 0.53 . . . . 0.0 110.937 -179.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.484 ' HB3' ' CD2' ' A' ' 33' ' ' HIS . 69.1 tp -109.92 124.93 52.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.527 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 79.8 ttt180 -125.45 134.5 52.06 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.476 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 25.4 m -78.57 92.52 4.7 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -63.82 -39.76 94.99 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.988 -0.551 . . . . 0.0 112.168 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 54.8 m -90.28 95.91 10.41 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.912 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 37.9 pt -83.79 -27.9 7.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.569 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -130.07 143.66 50.91 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.431 178.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.401 ' HB ' ' HB2' ' A' ' 52' ' ' ASP . 72.1 p -131.41 159.57 37.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.879 0.371 . . . . 0.0 111.746 -179.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -108.85 128.75 55.18 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 78.7 p -64.25 -37.27 86.88 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -128.36 72.77 80.23 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 112.295 0.479 . . . . 0.0 112.295 -178.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -72.65 159.56 48.46 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 122.493 2.129 . . . . 0.0 111.85 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.434 ' O ' ' HD3' ' A' ' 19' ' ' PRO . 20.5 p90 -76.27 168.26 20.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.907 0.384 . . . . 0.0 111.211 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.1 t-160 -109.62 98.34 32.35 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.403 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 17' ' ' PHE . 3.2 Cg_exo -81.91 124.11 4.34 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.959 2.439 . . . . 0.0 112.479 179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -83.14 -1.05 51.92 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.801 0.334 . . . . 0.0 111.202 179.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.6 m-85 -99.45 20.78 13.17 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.575 0.583 . . . . 0.0 112.575 -178.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 93.5 mt -76.94 120.95 28.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.874 0.369 . . . . 0.0 110.148 179.312 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -101.85 -35.8 8.89 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.532 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -132.14 144.35 50.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.852 0.358 . . . . 0.0 110.728 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.9 tt -127.02 110.79 13.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.24 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 40' ' ' ILE . 82.6 mtt85 -101.5 137.47 39.78 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.28 0.562 . . . . 0.0 111.456 179.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.4 t -117.46 129.08 74.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.064 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 77.9 mt -106.85 124.02 62.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 120.87 0.367 . . . . 0.0 110.789 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.16 147.71 48.09 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.067 179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 12.1 p -71.66 -53.01 14.97 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.5 -159.98 29.22 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.738 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -82.06 -24.13 4.11 Favored 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 122.043 1.829 . . . . 0.0 112.288 178.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.484 ' CD2' ' HB3' ' A' ' 5' ' ' LEU . 99.8 m-70 -73.06 -39.96 65.46 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 113.041 0.756 . . . . 0.0 113.041 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.1 m -112.85 131.84 55.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.754 0.311 . . . . 0.0 111.053 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.4 -39.66 93.97 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.209 -0.451 . . . . 0.0 112.139 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -129.35 158.1 40.07 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.849 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.4 p -71.5 158.11 36.83 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.654 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -129.69 139.61 51.32 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.796 0.331 . . . . 0.0 110.929 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.413 HD13 HG21 ' A' ' 62' ' ' VAL . 87.3 mt -120.8 129.63 75.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.118 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.678 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.9 tt -128.73 135.64 61.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.05 0.452 . . . . 0.0 110.443 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.577 HG12 ' HG ' ' A' ' 25' ' ' LEU . 27.1 m -112.78 148.08 16.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.066 0.46 . . . . 0.0 110.765 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -116.37 124.14 49.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.855 -179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -89.01 159.3 17.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.731 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 84.3 p -59.56 -21.21 59.96 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.415 -178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -86.34 5.2 35.85 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.075 179.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 81.03 25.85 54.53 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.026 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.7 mmt-85 -101.07 142.45 32.51 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.642 0.258 . . . . 0.0 110.923 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.678 ' HB3' HD11 ' A' ' 40' ' ' ILE . 98.6 mt-10 -116.04 131.38 56.96 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.828 0.347 . . . . 0.0 110.823 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -120.44 145.19 47.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.67 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 53.7 t -100.55 126.34 46.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.357 . . . . 0.0 111.409 -179.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 58' ' ' VAL . 84.7 mt -116.91 145.23 43.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.821 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.401 ' HB2' ' HB ' ' A' ' 12' ' ' THR . 45.4 t0 -108.59 113.74 59.64 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -63.72 -12.93 33.88 Favored 'Trans proline' 0 N--CA 1.479 0.663 0 C-N-CA 123.652 2.901 . . . . 0.0 115.514 -177.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -63.04 -21.43 66.16 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 118.142 0.428 . . . . 0.0 111.79 -179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -95.86 135.61 37.37 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.718 0.294 . . . . 0.0 111.224 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 60' ' ' ARG . 26.9 m120 -62.3 -39.03 91.64 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.503 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 7.5 t-105 -59.44 -45.03 92.75 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.159 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.443 HG13 ' HB3' ' A' ' 51' ' ' LEU . 63.4 t -62.52 -42.88 97.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 109.952 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 10.3 tp-100 -61.41 -38.22 86.33 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.556 179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.408 ' HG2' ' O ' ' A' ' 56' ' ' ASN . 27.4 mmm180 -59.96 -41.05 91.08 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.438 179.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 75.5 t -64.09 -46.51 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.995 0.426 . . . . 0.0 110.478 178.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.413 HG21 HD13 ' A' ' 39' ' ' ILE . 77.8 t -63.72 -47.26 91.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.656 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -64.24 -38.94 92.86 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.528 -0.306 . . . . 0.0 111.417 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -60.34 -46.89 88.31 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.415 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.425 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 47.6 m-85 -70.81 -36.53 73.0 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 120.71 0.29 . . . . 0.0 111.749 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 HD11 HD22 ' A' ' 25' ' ' LEU . 88.3 mt . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.312 -0.852 . . . . 0.0 111.133 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.97 0.414 . . . . 0.0 110.875 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.44 154.35 40.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.712 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.05 12.84 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.097 0.475 . . . . 0.0 110.754 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -125.64 146.65 49.62 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.873 179.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.9 mt -85.09 87.85 7.41 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.955 0.407 . . . . 0.0 110.516 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.5 mtp180 -127.45 140.87 51.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.613 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 99.7 m -99.06 159.15 15.17 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.241 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -61.86 -39.89 93.47 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.308 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 97.3 m -88.77 127.16 35.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.737 0.303 . . . . 0.0 110.697 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.8 pt -104.01 -9.55 9.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.805 179.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -147.93 137.57 22.46 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.142 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 69.8 p -129.64 160.24 33.93 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.444 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' CE2' ' HB2' ' A' ' 15' ' ' LYS . 9.2 t80 -101.93 117.57 35.11 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 87.0 p -93.44 -12.44 29.77 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.418 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 35.4 mmtp -84.61 122.78 74.92 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 121.099 -0.24 . . . . 0.0 110.77 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HA ' ' CD2' ' A' ' 57' ' ' TRP . 74.4 Cg_exo -54.67 129.39 34.75 Favored 'Trans proline' 0 C--N 1.349 0.567 0 C-N-CA 122.455 2.104 . . . . 0.0 112.794 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -160.93 137.17 8.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.586 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -119.4 90.64 42.82 Favored Pre-proline 0 C--N 1.329 -0.306 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.065 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -67.78 124.38 11.83 Favored 'Trans proline' 0 C--N 1.349 0.556 0 C-N-CA 122.556 2.171 . . . . 0.0 112.178 179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 35.6 mmtp -83.72 0.54 46.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.788 0.328 . . . . 0.0 111.452 179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -98.83 14.22 29.65 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 88.1 mt -75.22 119.61 23.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 120.938 0.399 . . . . 0.0 110.073 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -102.51 -42.96 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.524 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -130.41 149.69 51.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.009 0.433 . . . . 0.0 111.478 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.41 HD13 HG12 ' A' ' 41' ' ' VAL . 65.9 tp -118.52 122.03 41.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.375 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.634 ' HB2' HG23 ' A' ' 40' ' ' ILE . 99.7 mtt180 -109.48 143.73 38.71 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.015 0.436 . . . . 0.0 110.807 179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 65.4 t -114.7 128.97 71.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.376 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.408 ' HB ' ' HB2' ' A' ' 38' ' ' GLU . 81.5 mt -104.43 123.24 58.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.704 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.2 mm-40 -72.45 139.36 47.68 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.175 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 77.9 p -71.19 -42.14 69.4 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 -179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 67.83 -170.51 36.39 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.591 -179.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -74.43 -22.64 15.94 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.065 1.844 . . . . 0.0 112.316 178.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -71.14 -39.8 71.75 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -178.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.512 ' O ' ' HB2' ' A' ' 30' ' ' SER . 71.3 m -116.67 131.23 57.0 Favored 'General case' 0 N--CA 1.464 0.248 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.47 -40.39 95.61 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 115.969 -0.56 . . . . 0.0 112.217 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.9 p-10 -111.33 158.27 19.23 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.003 0.43 . . . . 0.0 111.783 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 79.8 p -83.11 166.38 18.75 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.465 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.496 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.5 mt-10 -125.24 143.44 50.95 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 120.929 0.395 . . . . 0.0 110.986 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.2 mt -117.49 127.92 74.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.221 -0.445 . . . . 0.0 109.997 179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.664 HD11 ' HB3' ' A' ' 48' ' ' GLU . 16.5 tt -127.32 137.66 57.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.168 0.508 . . . . 0.0 110.537 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.41 HG12 HD13 ' A' ' 25' ' ' LEU . 27.3 m -112.73 148.4 15.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.973 0.416 . . . . 0.0 110.745 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -114.66 123.14 48.55 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.75 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 7.1 mp -88.99 153.92 20.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.127 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.5 p -60.07 -19.5 53.39 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.597 0.561 . . . . 0.0 112.17 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -84.56 3.98 34.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.957 179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.93 56.72 Favored Glycine 0 C--N 1.336 0.546 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.233 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 89.5 mmt-85 -101.46 139.19 37.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.642 0.258 . . . . 0.0 110.872 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.664 ' HB3' HD11 ' A' ' 40' ' ' ILE . 97.6 mt-10 -117.44 129.29 55.74 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.672 0.272 . . . . 0.0 110.866 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.421 ' O ' HG13 ' A' ' 40' ' ' ILE . 87.7 mt -120.51 135.9 54.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.629 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 43.9 t -101.86 123.95 46.66 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.22 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 83.3 mt -117.29 148.04 42.03 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.79 -178.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -87.72 118.4 69.71 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.134 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -61.56 -19.34 64.36 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.171 2.581 . . . . 0.0 113.853 -178.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -68.18 -21.24 64.89 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.702 0.26 . . . . 0.0 111.702 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -82.83 133.59 35.13 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 121.007 0.432 . . . . 0.0 111.02 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -62.35 -40.51 96.64 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . 0.49 ' CD2' ' HA ' ' A' ' 16' ' ' PRO . 56.7 p-90 -64.0 -30.35 71.43 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.644 -179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.17 -40.69 89.96 Favored 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.043 0.449 . . . . 0.0 109.927 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.4 tp60 -60.96 -40.0 91.69 Favored 'General case' 0 C--O 1.23 0.07 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.317 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 92.7 mtm-85 -63.05 -38.34 90.8 Favored 'General case' 0 C--O 1.225 -0.19 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.553 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.582 ' O ' ' HD1' ' A' ' 65' ' ' PHE . 66.4 t -59.81 -47.57 90.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.377 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 31.6 m -78.06 -38.04 23.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -67.54 -44.63 77.87 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -64.65 -41.6 96.01 Favored 'General case' 0 N--CA 1.467 0.375 0 N-CA-C 112.669 0.618 . . . . 0.0 112.669 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' HD1' ' O ' ' A' ' 61' ' ' VAL . 41.0 m-85 -70.9 -34.88 72.01 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.712 0.292 . . . . 0.0 111.577 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 80.6 mt . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.27 -0.871 . . . . 0.0 111.034 179.679 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.471 0 CA-C-O 120.946 0.403 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -146.96 150.84 35.97 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.783 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -90.97 1.3 57.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -90.02 2.83 54.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.069 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.6 HD23 ' HB2' ' A' ' 33' ' ' HIS . 60.8 tp -79.06 119.29 21.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.685 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -146.51 147.54 31.27 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.238 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.517 ' HB3' ' OE2' ' A' ' 38' ' ' GLU . 8.5 m -76.31 93.6 3.47 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.72 0.295 . . . . 0.0 110.353 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -63.37 -41.14 98.8 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.082 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.7 m -93.28 93.13 8.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.659 0.266 . . . . 0.0 110.75 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.1 mm -63.72 -44.34 98.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.8 mmtm -116.43 141.31 48.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.967 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 71.1 p -130.12 158.46 39.6 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.413 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.418 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 24.5 t80 -108.48 138.74 44.29 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.657 ' O ' ' HG3' ' A' ' 55' ' ' GLU . 71.0 m -61.71 -41.45 97.62 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 46.3 pttt -131.8 72.84 79.48 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 120.911 0.386 . . . . 0.0 111.585 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.2 Cg_endo -72.07 156.23 56.07 Favored 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.752 2.302 . . . . 0.0 113.358 -179.209 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -88.47 131.01 35.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.843 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 -100.83 107.43 49.29 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 120.656 0.265 . . . . 0.0 110.79 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.58 153.51 34.51 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.734 2.29 . . . . 0.0 112.932 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -82.28 3.25 28.34 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.402 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.7 m-85 -98.12 20.2 12.79 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 83.7 mt -78.83 118.06 25.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -91.75 -45.74 8.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.01 -179.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -130.72 149.07 52.54 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.779 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.496 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.6 tt -124.88 114.7 19.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.457 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -107.33 136.39 47.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.206 0.527 . . . . 0.0 111.482 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.7 t -117.35 127.74 74.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.954 179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 79.2 mt -108.49 121.39 61.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.83 0.348 . . . . 0.0 110.719 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -71.22 144.28 50.16 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.081 -0.508 . . . . 0.0 109.83 179.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.424 ' O ' HD21 ' A' ' 5' ' ' LEU . 2.8 p -72.17 -54.48 9.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.68 -165.09 25.1 Favored Glycine 0 CA--C 1.52 0.405 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.113 -179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -74.93 -29.14 8.68 Favored 'Trans proline' 0 CA--C 1.533 0.474 0 C-N-CA 122.199 1.933 . . . . 0.0 112.676 178.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.6 ' HB2' HD23 ' A' ' 5' ' ' LEU . 92.3 m-70 -71.48 -38.38 71.24 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 15.0 t -113.53 128.46 56.45 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.555 -0.458 . . . . 0.0 110.742 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.58 93.05 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -178.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -127.31 139.97 52.52 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.6 0.592 . . . . 0.0 112.6 -177.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 57.5 m -64.72 137.64 57.92 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.595 178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.517 ' OE2' ' HB3' ' A' ' 7' ' ' CYS . 94.2 mt-10 -125.56 140.9 52.35 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 89.0 mt -118.74 130.73 73.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.478 HD11 ' HB3' ' A' ' 48' ' ' GLU . 20.5 tt -128.58 141.11 47.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.16 0.505 . . . . 0.0 110.676 -179.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.496 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.4 m -114.57 149.46 16.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.095 0.474 . . . . 0.0 111.042 -179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -110.6 122.34 47.54 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.178 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.513 HD12 ' HB2' ' A' ' 47' ' ' ARG . 82.0 mt -90.27 153.17 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.559 -179.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 85.7 p -60.57 -19.88 58.82 Favored 'General case' 0 N--CA 1.465 0.306 0 O-C-N 123.69 0.619 . . . . 0.0 112.124 -178.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -85.13 4.22 35.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.857 179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.68 20.94 58.93 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.324 -179.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.513 ' HB2' HD12 ' A' ' 43' ' ' LEU . 96.5 mtt-85 -101.26 158.81 15.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.943 0.401 . . . . 0.0 111.545 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.3 mt-10 -128.1 133.33 49.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.059 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.4 mt -123.9 142.54 51.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.215 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 70.8 m -100.12 133.14 44.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.924 0.392 . . . . 0.0 111.294 -179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.71 148.34 39.87 Favored 'General case' 0 C--O 1.236 0.366 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.686 -179.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -98.64 110.41 56.92 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.867 -179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.49 -14.3 36.73 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.086 2.524 . . . . 0.0 113.54 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 5.2 mmmm -61.68 -37.08 82.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.315 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.657 ' HG3' ' O ' ' A' ' 14' ' ' SER . 77.5 mm-40 -77.29 127.88 33.37 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.924 0.393 . . . . 0.0 110.724 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -62.84 -40.34 97.13 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.4 p-90 -64.52 -32.8 74.6 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.353 -178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 63.8 t -63.87 -43.23 97.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-O 120.845 0.355 . . . . 0.0 110.264 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -61.22 -41.41 96.82 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.741 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 27.6 mmm180 -62.18 -42.9 99.71 Favored 'General case' 0 CA--C 1.519 -0.241 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.466 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 79.6 t -64.51 -46.0 94.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.601 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.1 t -62.65 -49.2 84.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.77 -43.06 89.99 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 111.807 0.299 . . . . 0.0 111.807 -179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -68.0 -40.04 83.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.978 179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -62.37 -48.59 79.08 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 111.126 179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 29.4 tp . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.943 -179.521 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 120.979 0.418 . . . . 0.0 110.903 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.32 156.61 42.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.662 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.95 17.06 24.81 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.998 0.427 . . . . 0.0 111.084 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -110.34 130.66 55.51 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.137 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 86.9 mt -78.14 77.51 4.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 110.869 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 27.8 tpt180 -146.5 138.97 25.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.051 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 89.5 m -86.19 145.57 26.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.818 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -62.27 -40.86 97.62 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 121.066 0.46 . . . . 0.0 110.669 179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 65.2 m -105.99 105.46 15.51 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.631 HG22 ' HG3' ' A' ' 11' ' ' LYS . 97.1 mt -63.24 -47.2 93.31 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.845 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.631 ' HG3' HG22 ' A' ' 10' ' ' ILE . 64.4 mttp -132.21 149.01 52.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.799 0.333 . . . . 0.0 111.303 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.1 p -129.8 156.92 43.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.128 178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.422 ' O ' ' HD3' ' A' ' 16' ' ' PRO . 35.9 t80 -108.7 142.46 39.17 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.363 -0.236 . . . . 0.0 110.363 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 80.6 p -62.04 -35.64 79.21 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 -179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -128.58 73.53 80.66 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 120.505 0.193 . . . . 0.0 110.964 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 13' ' ' TYR . 74.4 Cg_endo -72.31 156.74 54.57 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.652 2.235 . . . . 0.0 113.159 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -86.88 143.54 27.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.105 179.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.535 ' CG ' HG11 ' A' ' 61' ' ' VAL . 95.5 m-70 -119.06 90.95 42.58 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.605 -0.271 . . . . 0.0 111.268 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.22 147.74 94.47 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.195 2.597 . . . . 0.0 112.582 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.8 mtmm -81.06 3.27 23.82 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.914 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -96.52 16.37 18.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.892 -179.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 90.1 mt -76.06 118.38 22.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -92.74 -44.34 8.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.059 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 78.9 mm-40 -130.62 149.18 52.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.972 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.661 ' HG ' HG12 ' A' ' 41' ' ' VAL . 1.4 tt -124.42 115.91 21.69 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 84.6 mtp180 -108.31 132.23 53.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.32 0.581 . . . . 0.0 112.046 -179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 64.8 t -122.49 128.47 75.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.381 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 44.6 pt -121.1 148.63 24.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 121.105 0.479 . . . . 0.0 111.776 -179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -76.95 148.95 36.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.084 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' A' ' 34' ' ' CYS . 79.5 p -70.59 -40.56 73.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.713 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 61.88 -156.62 36.27 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 121.003 -0.618 . . . . 0.0 111.922 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -80.87 -20.09 7.91 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.167 1.911 . . . . 0.0 112.217 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -70.76 -40.18 72.81 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.498 -178.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 30' ' ' SER . 97.6 m -124.48 149.08 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.796 0.331 . . . . 0.0 111.436 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.67 -4.58 55.01 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -137.05 139.9 41.66 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.744 0.307 . . . . 0.0 111.6 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 62.6 m -64.62 137.41 57.82 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.083 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 79.5 mm-40 -112.99 132.89 55.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.073 0.463 . . . . 0.0 111.753 -178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 86.1 mt -117.53 130.28 72.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.535 HD11 ' HB3' ' A' ' 48' ' ' GLU . 19.9 tt -132.15 144.18 37.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.135 0.493 . . . . 0.0 110.896 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.661 HG12 ' HG ' ' A' ' 25' ' ' LEU . 30.7 m -115.16 149.27 17.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.969 0.414 . . . . 0.0 110.759 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -114.37 119.54 37.3 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.423 -179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.63 153.18 20.94 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.328 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.0 p -60.53 -20.13 59.31 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.917 -0.583 . . . . 0.0 112.063 -178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.52 4.09 37.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.839 179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 83.11 22.46 57.25 Favored Glycine 0 C--N 1.336 0.534 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.22 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 31.4 mmm180 -100.89 144.15 30.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.769 0.318 . . . . 0.0 111.118 -178.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.535 ' HB3' HD11 ' A' ' 40' ' ' ILE . 96.6 mt-10 -121.29 130.28 53.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.995 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 89.0 mt -122.4 141.7 51.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.426 179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 87.5 m -97.06 134.64 40.14 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.987 0.422 . . . . 0.0 111.392 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 77.1 mt -116.28 144.15 44.61 Favored 'General case' 0 C--O 1.238 0.466 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.778 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -96.55 116.51 66.16 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.142 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.06 -13.25 39.17 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 123.291 2.66 . . . . 0.0 113.946 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -61.52 -38.43 87.37 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 111.652 0.242 . . . . 0.0 111.652 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 56.0 mp0 -79.63 127.66 32.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.104 0.478 . . . . 0.0 110.751 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.1 p-10 -69.19 -35.62 76.45 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 112.759 0.652 . . . . 0.0 112.759 -178.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.7 p-90 -65.21 -31.81 73.17 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.635 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 64.0 t -64.6 -42.11 94.17 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -61.78 -38.24 87.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-N 115.562 -0.745 . . . . 0.0 110.59 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 78.0 mtp85 -60.48 -41.31 93.97 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-N 116.285 -0.416 . . . . 0.0 109.888 179.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.535 HG11 ' CG ' ' A' ' 18' ' ' HIS . 78.8 t -65.1 -44.33 95.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.292 178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 64.4 t -61.47 -47.13 94.8 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.186 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.843 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -64.45 -39.58 94.1 Favored 'General case' 0 CA--C 1.522 -0.104 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.357 179.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.7 tttp -61.24 -46.03 92.1 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.284 179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -68.1 -38.15 81.99 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.436 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 C--O 1.25 1.082 0 CA-C-O 118.326 -0.845 . . . . 0.0 111.171 179.915 . . . . . . . . 0 0 . 1 stop_ save_